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This dissertation examines immunization as a health behavior and investigates 
factors that influence vaccination acceptance. Chapter I describes the background and 
literature review, outlining a brief history of communicable diseases, public health and 
immunization development as wel as the history and definitions of theories and 
models of health behavior and health promotion. The author explores the health belief 
model (HBM), the most popular health behavior model for vaccinations. Curent and 
past vaccination systems in the world and Japan are also examined to find 
characteristics and issues that Japan currently must address. From the literature review, 
two current public health problems related to vaccinations were selected as research 
questions. They were the increase in complications from natural mumps because of the 
mumps vaccination rate drop and excess mortality during influenza seasons mainly in 
the elderly population due to the low vaccination rate of seasonal influenza vaccines. 
Chapter I describes the common background and methodology in the studies in 
this dissertation for the two questionnaire surveys. Study I surveys the maternal 
population to investigate factors that influence not vaccinating their children against 
mumps; Study I surveys the elderly people in a community to investigate factors that 
afect seasonal flu vaccination uptakes. One of the major pilars in this dissertation is 
methodology research. This chapter presents the literature review and describes the 
mixed method research. Proper quantitative analysis is discussed and the reason for the 
method used in the studies in this paper. 
Chapter II describes Study I: Factors associated with mothers not vaccinating their 
children against mumps in Japan. In this chapter, the author targeted the maternal 
population to explore the factors influencing the low mumps vaccination rate of 
children. Another pilar of the studies in this paper was to investigate the HBM 
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analysis of vaccination behavior. These factors were extremely helpful in the analysis. 
We found factors including HBM factors that afected maternal awareness for vaccine 
uptake of their children at the individual level and other factors that must be considered 
more broadly at ecological levels. 
Chapter IV describes Study I: Seasonal flu vaccination acceptance among the 
elderly who live in a community in Japan. In Study I, we analyzed factors of 
characteristics, HBM factors and factors known to influence health for elderly 
populations such as Self-Rated Health and social activities and participation. We found 
factors afecting seasonal influenza vaccination uptakes among the population. HBM 
factors were proven to be useful predictors in the study. This chapter describes the 
results and findings of a quality analysis of an open-ended question to address the idea 
for influenza vaccinations. 
Chapter V summarizes and presents the conclusions from Studies I and I. Chapter 
V especialy focuses on the wrapping up methodology applied in the studies in this 
paper and the results of the HBM analysis focusing on common and diferent factors 
between Studies I and I, comparing them with previous studies. Chapter V includes 
implications obtained from the studies and proposes an ecological model for health 
promotion to address the public health issues as objectives presented in this paper. 
The author shows the flow of studies in this thesis in Chart 1 below
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Flow chart 1: Outline of the study 
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1.1 Emergence of infectious diseases and establishing a vaccination 
system 
In public health history, controling infectious diseases and the invention of 
vaccinations are very important. The history of pneumonia started at least several 
thousand years ago. In the Middle Ages, infectious diseases cost many human lives; the 
spread of plague, smalpox and measles was severe in the 14th century; communicative 
disease fatalities were one-third of the total population (2). When 8 to 20 percent of the 
total death rate was due to smalpox in some European countries in the 18th century, E. 
Jenner (1749-1823) discovered people inoculated from cowpox residue did not develop 
smalpox later (1). L. Pasteur (1822-1895) further developed inoculation and 
established vaccination in the 19th century, focusing on immunology (2). K. Frankel 
(1861-1915), E. Behring (1854-1917) and S. Kitasato (1852-1931) developed serum 
therapy for tetanus that lead to immunization against other infectious diseases today (3). 
Along with this immunization development, the epidemiology development first 
established by J. Snow (1813-1858), who found the source of a cholera outbreak was a 
cholera germ named Vibrio Cholerae in London in 1854, contributed to modern public 
health history (1, 37). 
 
1.2 Vaccinations as health behavior 
1.2.1 Health behavior 
Health behavior has many definitions. In the 1950s, the Medical Education 
Commitee of the American Medical Association (AMA) recommended al medical 
education institutions incorporate human behavior as a basic academic discipline. Since 
then the role of human behavior in medical education and health promotion has 
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attracted atention (28). Matarazzo defined Behavioral health as an interdisciplinary 
field dedicated to promoting a philosophy of health stressing individual responsibility 
in applying behavioral and biomedical science knowledge. He also established 
techniques for maintaining health and preventing ilness and dysfunction through a 
variety of self-initiated individual and shared activities (29). Parsons analyzed that 
sickness goes beyond disease and defined that people who have falen il have rights 
and obligations within social norms: “1) The sick person is exempt from normal social 
roles, 2) the sick person is not responsible for their condition and obligations; 2) the 
sick person should try to get wel, 3) the sick person should seek technicaly competent 
help and cooperate with the medical professional (16).” Kasl and Cobb (1966) define 
three categories of health behavior: 1) preventive health behavior, 2) ilness behavior 
and 3) sick-role behavior(s) (19). Adhering to this definition, Gochman defines health 
behavior as an individual’s beliefs, expectations, motivations, concepts and other such 
factors that include preventive and adaptive behavior relating to health maintenance, 
restoration and improvement (15, 20).  According to this definition, health behavior 
includes utilizing health services such as physician visits, vaccinations and screenings, 
adhering to treatment and voluntary healthy behavior including a proper diet, sleeping, 
exercise and not smoking. 
 In this paper, the definition of health behavior folows Gochman’s definition and 
considers the atitudes and actions concerning vaccination as a health behavior (21). 
 
1.2.2 Health behavior and health promotion 
Along with the development of health behavior study, epidemiological researchers 
focusing on health behavior and lifestyle factors including diet, smoking and exercise 
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increased. The most wel-known relevant research was the Framingham Heart Study, 
which started in the 1940s; clinical and physical factors as wel as lifestyle factors were 
researched to study the risk factors for cardiovascular diseases of people in 
Framingham, Massachusets, USA.  
Health was defined as “… a state of complete physical, mental and social wel-
being and not merely the absence of disease or infirmity” in the Constitution of the 
World Health Organization in 1946. 
After that the Declaration of Alma-Ata was adopted at the International 
Conference on Primary Health Care convened in Alma-Ata, Kazakhstan in September 
1978, the member countries set “Health for Al” as a goal and recognized the 
importance of primary health care and health promotion (163). 
In the first International Conference on Health Promotion in Otawa organized by 
The World Health Organization (WHO), health promotion was defined as “the process 
of enabling people to increase control over, and to improve, their health”. The Otawa 
Charter was established to achieve “Health for Al by the year 2000 and beyond” (120). 
At this conference, the importance of supporting education and the social environment 
to facilitate healthy behaviors and lifestyles was proposed. To provide a framework for 
environment and public policies to urge healthy behaviors in the population, Healthy 
People 2000 in the United States and Healthy Japan 21 were established after (37). 
 
1.2.3 Health behavior theories and models 
1.2.3.1 Health Belief Model 
Many health education intervention theories and models have been created to 
facilitate health education. 
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The oldest health behavior model that explains health behavior at the individual 
level is the Health Belief Model (HBM). Hochbaum (1958) first developed HBM in the 
1950s to examine why people failed to undergo tuberculosis screening when they 
believed that they were susceptible to tuberculosis and recognized the benefits of the 
screening tests. HBM was later formulated by Becker et al. who defined key constructs 
such as perceived susceptibility to disease, perceived severity of disease, perceived 
benefits, perceived bariers, perceived self-eficacy and cues to action (17, 18). HBM 
has been and is stil widely used to analyze individual preventive behaviors such as 
HIV/AIDS-related prevention behaviors (141, 147) and breast cancer screening 
behaviors (143, 144). 
 
1.2.3.2 Another behavior models 
Another significant development of health behavior and health education theory is 
Social Cognitive Theory as Social Learning, Miler et al. (1941) first established as 
Imitation Theory of behavioral change in the psychological field.  Bandura 
conceptualized as Social Learning through Imitation (1962) where Roter added 
concepts of expectancy to internal and external control for self-reinforcement in 1954 
(165). 
Bandura defined and named as Social Cognitive Theory (SCT) from Social 
Learning Theory in his 1986 paper (124). The current SCT components are the 
environment, situation, behavioral capability, expectations, self-control, observational 
learning, reinforcements, self-eficacy, emotional coping responses and reciprocal 
determinism (125, 126, 127). SCT has been applied to health education programs. One 
of the most popular health behavior intervention programs adopting SCT is the Gimme 
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5 "let's eat more fruits and vegetables" program to improve children’s eating habits. 
This nutrition intervention program especialy focuses on observational learning where 
children tend to imitate the behaviors of others and to improve their environments such 
as homes and schools. This program was established in 1993 (Domel and al.) and has 
repeatedly been used in schools and homes and become a national program in the US 
(146). 
The next significant health education model is the Transtheoretical Model (TTM) 
that Prochaska first established from psychotherapy therapies in 1984 (123). The theory 
focuses on which stage individual behavior is on, using a continuum with 
contemplation, preparation, action, maintenance and termination. TTM looks for the 
leverage to intervene to change behaviors. 
The Theory of Reasoned Action (TRA), which was first proposed by Fishbein in 
1967 and formulated with Ajzen in 1975, is another health education theory.  They 
insisted that the most important determinant factors for health behavior are subjective 
norms and the intention to perform a behavior (121). Later Ajzen and Driver added 
recognizable behavioral control as a new factor and established the Theory of Planned 
Behavior (TPB) in 1991 (122). Many programs for promoting participation in exercise 
and physical screening tests use TRA and TPB (128, 129). 
The Transactional Model of Stress and Coping (TMSC) is another significant 
behavioral model. Lazarus and Cohen (1977) first formulated it in 1977 to address 
stressful events. They thought a stressful event was mediated by the first appraisal of 
the afected person, folowed by the afected person’s second appraisal of the 
psychological, social and cultural resources at his or her disposal (Lazarus & Cohen, 
1977; Antonovsky & Kats, 1967; Cohen 1984) (140). TMSC has been used in stress 
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coping programs for patients with HIV/AIDS and breast cancer or other stress coping 
programs (130, 131, 148). 
 
1.2.3.3 Health Belief Model and vaccinations 
As specifying each construct of HBM is comparatively easy, HBM has been used 
widely from the 1950s by health behavior researchers of preventive behaviors and to 
obtain insights and frameworks for health behavior interventions at the individual level. 
HBM is the most popular health behavior model in vaccination behavior research 
covering influenza (134, 135), pertussis (136) and other uptake studies. Brewer et al. 
performed a meta-analysis of thirty-four HBM based vaccination behavior studies 
(N=15988) and analyzed each constituent of HBM such as perceived susceptibility, 
perceived severity and perceived likelihood.  They found that al the constituents 
significantly associated with vaccination behaviors were efective determinant factors 
(137). 
Some studies in health behavior such as nutrition uptake and smoking cessation 
have used HBM theory in Japan (158, 166). Recently we have observed vaccination 
studies based on HBM analysis in Japan, however, the number is stil enough (57, 138). 
 
1.3 Social factors and health 
1.3.1 Social factors 
Many studies investigate the influence of social factors such as income, living 
places, social activities, social connections or social networks and social support on 
health (151, 154, 155). Kondo et al. reported that not only life styles such as smoking, 
exercises, dietary habits, sleeping but also health outcomes such as oral health, 
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anxieties, depression and others were influenced by social factors (31, 157). 
Cohen defined social integration as including social roles, social participation, a 
sense of belonging to one’s community, self-expectancy for one’s status, social 
networks, contribution to the community and social networks of friends or families 
(1988). Cohen et al. indicated that as people are beter socialy integrated, they can 
more easily obtain beneficial information resources for their health (152). Social 
networks and social support have extended to social capital including social 
characteristics such as social norms, trust and social networks (Putnam 1993) (149). 
There are a various definitions about social capital from macro or micro perspectives 
and sociology or public health perspectives so that a definition is not made in this paper. 
Kawachi suggests in his book that people benefiting from beter social capital have 
reported beter health than those with lower social capital (176). 
Social networks and social support are known to influence Health Behavior, 
including preventive behavior such as smoking secession and dietary habits. In 
immunization studies, cues to action factors of HBM such as friends’ or relatives’ 
recommendation, family doctor’s advice and support relevant to social networks are 
shown to influence on immunization activities (135).  
 
1.3.2 Social and cultural factors and health service usage 
The Organization for Economic Co-operation and Development (OECD) utilizes 
preventive services such as the mammography, Pap smear screening test ratio and 
influenza acceptance ratio among the elderly 65 years and older as health care quality 
indicators. Many studies investigate social factor influences on these indicators; many 
of these studies suggest that these indicators decline in low socio-economic status and 
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low hospital density locations such as rural places (53, 161, 54, 162). Casey et al. using 
a large scale database Behavioral Risk Factor Surveilance System (BRFSS) and Area 
Resource File in the Unites States, have shown that preventive service usage such as 
Fecal occult blood test (FOBT), proctosigmoidoscopy, mammogram, pap smear 
screening test and influenza vaccination significantly declined in the population living 
in rural places (53). 
For immunization behaviors, Nagata (Jason) et al. suggested in their systematic 
review of 58 both qualitative and quantitative studies about seasonal influenza vaccine 
uptake in the elderly population and concluded that social determinants were the most 
important factors to influence seasonal vaccination uptakes (56). 
Similarly, Cultural factors, genders, and ethnicity are known to influence on 
immunization acceptance (52). Ward et al. argued how culture determines cognition for 
immunization behavior of acceptance or rejection by adopting comprehensive 
sociocultural understandings (178).  Pleis et al. reported a cultural and biological 
diference of gender (male and female) in seasonal influenza vaccination acceptance 
using a large scale data of the National Health Interview Survey (58).  
In Japan, there are studies about the efect of social factors on health care services. 
Endo et al. (2004) have shown unfair access for low-income people to health care 
services from 1984 due to the aging society (169). Some children’s studies suggest that 
the parental income efect for their children’s hospital or health service usage is limited 
(167, 168). In gerontology studies, Yamada suggested that elderly people with low 
income accessed home long-term care service below their needs, but this has been 
ameliorated since 1998 (170). However, the number of these studies especialy about 
preventive service is stil low in Japan, even if we include other preventive service 
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studies such as cancer screening and mammographies (57, 157，171). 
 
1.4 Current vaccination systems 
1.4.1 Vaccination in the world today 
The WHO issues vaccine position papers for vaccine preventable diseases (VPD) 
to al member countries providing recommendations and strategic plans to achieve 
regional goals (39). The WHO also regularly disseminates information about infectious 
diseases, epidemiological reports and vaccine safety reports, using WER (Weekly 
Epidemiological Records) (40). 
The Global Vaccine Action Plan (GVAP) adopted by the 194 Member States of 
the WHO in May 2012 provide clear five goals (118). They are 1) Achieve a world free 
of poliomyelitis,  2) Exceed the Milennium Development Goal 4 target for reducing 
child mortality, 3) Meet global and regional elimination targets, 4) Meet vaccination 
coverage targets in every region, country and community, 5) Develop and introduce 
new and improved vaccines and technologies in order to prevent milions of deaths by 
2020 by expanding vaccination access for people in al communities. 
GVAP strengthen routine immunization to meet vaccination coverage targets; 
accelerate control of vaccine-preventable diseases with polio eradication as the first 
milestone; introduce new and improved vaccines and spur research and development 
for the next generation of vaccines and technologies（41）. Under this action plan, the 
WHO estimates that 24 - 26 milion child deaths can be prevented if al countries use 
10 vaccines (hepatitis B, Haemophilus influenza type b, human papilomavirus, 
Japanese encephalitis, measles, meningococcus A, pneumococcus, rotavirus, rubela 
and yelow fever) and targeted 94 countries to achieve the goal during this decade 
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（42）. 
 
1.4.2 Vaccination in Japan today 
Modern infectious disease law in Japan started with the Communicable Diseases 
Prevention Law enacted in April 1897; only severe and fatal infectious diseases were 
stipulated such as cholera, dysentery, typhoid, variola, epidemic typhus, scarlet fever, 
diphtheria and plague. Due to the progress in sanitation, medicine and public health 
along with the vaccination system, we can now live free from problems concerning 
these communicable diseases. The modern Preventive Immunization Law was 
established in 1948 where smalpox, typhoid fever, diphtheria, tetanus, and acelular 
pertussis (DTP) was included as immunization program (2). The curent infectious 
diseases and vaccination systems were established under the Infectious Diseases 
Control Law enacted in 1999 (2). 
 
1.4.2.1 Routine immunization system 
Under the curent National Law amended in December 2013, Type I Disease care 
is defined as “implementing immunization to prevent outbreaks of infectious diseases 
or epidemics, contributing to the improvement and promotion of public health as wel 
as providing swift relief for health damages resulting from vaccinations.” The diseases 
include diphtheria, pertussis, polio, measles, rubela, Japanese encephalitis, tetanus, 
tuberculosis, Hib, HPV, pediatric streptococcus pneumonia and smalpox. Influenza 
vaccination was included in NIP as the classification of Type I Disease for those 65 
years old and older and for those from 60 to 64 with chronic cardiac, respiratory and 
renal diseases. This was defined as “implementing immunization to prevent individuals 
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from contracting a disease and, if they do contract the disease, to reduce the severity of 
the disease, thereby contributing to public health” in 2001.  
Under the Preventive Vaccination Law, combined diphtheria, tetanus and acelular 
pertussis vaccination (DTaPI), combined diphtheria and tetanus I, combined measles 
and rubela (MR), Bacilus de Calmete-Guerin (BCG), polio and Japanese encephalitis 
are incorporated in the national immunization program and are recommended for 
mandatory vaccination (38).   
With the recent amendment to the Preventive Vaccination Law in Japan, 
haemophilus influenza type b (Hib), human papilomavirus (HPV) and pediatric 
streptococcus pneumonia were added to the routine vaccination schedule in March 
2013 by amending the Vaccination Law, Act No. 69 of 1976. However, the 
government had withdrawn a recommendation for HPV vaccine due to frequent reports 
of side efects. 
Curently, the WHO recommends BCG, hepatitis B, polio, DTP, Hib, 
pneumococcal (conjugate), rotavirus, measles, rubela and HPV for al population and 
mumps, seasonal influenza and chicken-pox for certain populations (117).  The 
Japanese vaccination system had a long delay compared to other developed nations 
(48). The term caled ‘vaccine gap’ had been used for a long time to express the delay 
(82) up to amending the Preventive Vaccine Law to add the three vaccinations for Hib, 
HPV and streptococcus pneumonia in 2013.  Folowing the amendment, chicken pox 
vaccination that was delayed significantly was included in 2014 (119). However, 
seasonal influenza, mumps, hepatitis A and B and rotavirus vaccinations are not 
mandatory yet.  
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1.4.2.2 Non-mandatory immunization system 
Curently, seasonal influenza for those 64 years of age and below, mumps and 
hepatitis A and B vaccinations are not stil mandatory. One hundred and seventy-seven 
WHO member countries have already included a hepatitis B vaccination program in 
NIP in 2008 and 118 have included mumps vaccination.  
No national surveilance data exists for non-mandatory vaccinations so that the 
correct vaccination rates among eligible children are unknown, but it is estimated to be 
about 5 percent for Hib vaccination, 30 percent for mumps and 50 percent or below for 
seasonal influenza in children (1,2,3). 
 
1.4.3 Immunization and related issues in Japan 
1.4.3.1 MMR combination vaccine 
The WHO recommends including the Mumps, Measles, Rubela (MMR) 
combination vaccine in mandatory vaccinations, but the MMR is not used in Japan. In 
1989, the first MMR combination vaccine (Kitasato AIK-C measles, Biken’s Urabe 
Am9 mumps and Takeda To336 rubela) was authorized and introduced as a mandatory 
vaccine in the national immunization program (NIP). Takeda MMR (Schwarz FF8 
measles, Tori’s mumps and To336 rubela), Kitasato MMR (Kitasato AIK-C measles, 
Hoshino mumps and Takahashi rubela) and Biken MMR (Tanabe measles, Urabe 
Am9 mumps and Matsuura rubela) folowed this （67）. During this period, many side 
efects, mainly aseptic meningitis, were reported, three children died, four were 
handicapped and 10,032 needed medical assistance (4). The incidence of aseptic 
meningitis was reported to be from 1 in 500 to 900 vaccines to 1 in 1200 (70, 71). 
There was concern that mumps vaccines contained in MMR vaccines caused these 
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adverse events (67,83, 84, 85, 86, 87, 89); the Ministry of Health, Welfare and Labor 
conducted nationwide surveys and tested mumps viruses isolated from cerebrospinal 
fluid for their relation to the mumps vaccine, using nucleotide sequence analysis
（67,68,88）. As a result of these surveys and tests, the Urabe strain included in mumps 
vaccines was identified as the cause. In 1993, the MMR was subsequently withdrawn 
from NIP in Japan (4,70). Since then a measles and rubela (MR) combination vaccine 
has been given in NIP and a single dose mumps vaccine (Hoshino-L32 or Tori) has 
been used as a non-mandatory vaccine. 
 
1.4.3.2 Measles outbreaks and measles immunization 
Measles is a severe communicable disease; the fatality rate may reach 20 percent. 
In 2000, many lives were lost due to measles outbreaks and about 40 percent of a total 
of 1.4 milion deaths from VPD worldwide was estimated to be from measles (118). 
The WHO established objectives to strengthen vaccine dissemination in the African 
Region (AFR) and the South-East Asia Region (SEAR) to decrease the number of 
measles deaths. The WHO verified measles elimination in the European (EUR) and the 
Eastern Mediteranean Regions (EMR) by 2010, and the Western Pacific Regions 
(WPR) including Japan by 2012. Under these goals, the annual estimated measles 
deaths declined by 72 percent in 2013 (118). 
In Japan, a measles outbreak was observed mainly in a population of smal babies 
in 2001 and 286,000 cases were reported. This outbreak was due to the measles 
vaccination rate decline caused by the MMR vaccination withdrawal from NIP in 1993 
and the measles vaccination rate of the population was estimated to be about 50 to 60 
percent (69, 104). Since then, the measles vaccination has been mandated to be taken 
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twice and improving the national surveilance data system was set as a goal (103). 
The Japanese Government partialy amended the Preventive Vaccination Law on 
July 29, 2004; the first and the second doses of the MR combination vaccine were 
mandated to be taken 12 to 24 months and 5 to 7 years after birth. However, an 
outbreak was observed in 2007 and 2307 measles cases were reported mainly in the 
single dose vaccination population with a median age of 17 years old, of which 44 
percent were ten years old and older and the highest age group was the 20 to 24 year 
old adult population with many severe cases (105). The United States had already 
declared measles eliminated in 2000 and Japan was regarded as a measles exporting 
country (106). For this reason, a temporary measure was taken for five years starting 
from 2008 and a third additional dose was given to first year junior high school 
students folowed by a fourth dose for senior high school students. Due to this 
temporary measure, the measles vaccination rate increased to 95 to 98 percent; reported 
cases dropped as low as 232 in 2013. 
 
1.4.3.3 Rubela outbreak and rubela-containing immunization 
When children contract rubela, many cases are mild. However, when pregnant 
women contract rubela, 90 percent of fetuses contract the disease from vertical 
transmission from the mother. The transmission causes congenital rubela syndrome 
(CRS) including heart disease, hearing loss and eyesight and mental disorders in the 
fetuses. In 2000, WHO published its first position paper on rubela vaccine to guide the 
introduction of rubela-containing vaccines (RCVs) into national childhood 
immunization schedules (109). Under this recommendation, the Americas (WHO 
definition) achieved the goal of eliminating rubela and CRS by 2010, folowed by 
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EUR in 2015.  However, many countries in the WRPO, AFR and SEAR have lagged 
behind in introducing RCVs; many rubela and CRS cases were reported (109). 
In Japan, vaccination with RCVs started in 1976 and they were incorporated in 
NIP for female junior high school students. As mentioned in the measles discussion 
above, MMR vaccinations started in 1976 in NIP and were withdrawn due to the 
aseptic meningitis in 1993. A single dose rubela vaccine has been used since then, but 
the rubela vaccination rate significantly declined. To resolve the low vaccination rate, 
additional rubela vaccinations were administered to students at junior high school in 
2003. Reported vaccination rates of both males and females were as low as 20 to 30 
percent. Under the Preventive Vaccination Law, two doses of MR were mandated from 
2006 and two additional doses added for first year students at junior and senior high 
schools (103). However, from 2012 to 2013, rubela outbreaks were observed in Japan 
with approximately 15,000 cases including 32 CRS cases reported (107). The reported 
cases were mainly from the adult male population who did not have RCVs before 1979 
when only girls had the RCVs. The majority of cases reported were from 20 to 45 year 
old males with the most frequent reported age of 35. Given these circumstances, RCVs 
were additionaly administered to male adults; the number of reported cases dropped to 
320 in Japan in 2014 (108). 
 
1.4.3.4 Polio immunization 
The WHO promotes the Polio Global Eradication Initiative; nearly one year has 
passed since the last wild polio case was reported on the African continent on August 
11, 2014. In the entire world, only Afghanistan and Pakistan have not declared polio 
eradicated. The WHO set a new objective to eradicate polio by 2018 from the world 
  
26 
 
(110). 
In Japan, the last polio outbreak was reported in 1960 when approximately 6500 
cases were reported al over Japan. Live atenuated oral polio vaccine (OPV) made 
from monkey kidney cels was included in NIP from 1961. Due to this vaccine program, 
reported wild polio cases were eliminated by 1980 (103). However, due to the spread 
of OPV, 8 to 10 cases of vaccine-associated paralytic polio (VAPP) have been reported 
annualy. In the US, OPV was changed to inactivated poliovirus vaccine (IPV), but 
OPV was continuously used in NIP until 2012 when OPV was changed to IPV and 
VAPP was been reported every year after wild polio was eradicated in 1980 (111). 
 
1.4.3.5 Tuberculosis incidence and BCG immunization 
Tuberculosis is stil a life-threatening disease folowing HIV/AIDS and 9 milion 
tuberculosis cases were reported in 2013 of which 1.5 milion people, mainly in low 
socio-economic classes, died (112). The WHO set up an End Tuberculosis Strategy to 
1) push down global tuberculosis (TB) incidence rates from an annual decline of 2 
percent in 2015 to 10 percent by 2025 and to 2) Reduce the proportion of people with 
TB who die from the disease from 15 percent in 2015 to 5 percent by 2025 (113). 
The most effective prevention for TB is BCG vaccination. However, infants with 
a depressed immunological state such as being HIV positive have revealed that they 
risk developing TB through BCG vaccines (116). Thus BCG vaccines have been 
withdrawn in some areas in the world, which has raised new concerns (114). In Japan, 
the Tuberculosis Prevention Act was enacted in 1951 when 500,000 cases were 
reported annualy, of which 93,000 resulted in deaths (2). After BCG vaccines spread 
widely, a vaccination rate of more than 95 percent was achieved, especialy for 
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newborns.  Reported TB cases have significantly declined, but 19,615 TB cases were 
reported in 2014 of which 58.2 percent of the cases consisted of the elderly who were 
70 years old and older compared to 0.2 percent among those 0 to 14 years old. TB is 
stil a major concern in Japan (115). 
 
1.4.3.6 Seasonal influenza outbreak and immunization among elderly population 
In 2009, the H1N1 influenza pandemic occurred in the world and Japan, people 
rushed to have swine flu vaccinations at hospitals and the H1N1 vaccine shortage 
became an issue. However, seasonal influenza outbreaks occured cyclicaly before the 
swine flu panic and have become a significant public health issue, costing many lives 
in the world and Japan (91). Influenza specificaly afects the elderly and people with 
fragile health, causing respiratory diseases such as pneumonia and bronchitis as wel as 
aggravating cardiovascular and cerebral vascular diseases that cause many deaths every 
year (95). According to CDC, from 1990 to 1999 influenza seasons, more than 32,000 
deaths in the US each year among the elderly population 65 years and older were 
caused by influenza complications (96). The WHO analyzes influenza virus 
surveilance data with an expert panel and issues recommendations for the world on the 
composition of the influenza vaccines for the folowing influenza season and on being 
vaccinated (92). The WHO recommends that high-risk populations such as pregnant 
women, the elderly, infants, the immune-compromised and people with chronic 
conditions have priority for immunization (93). In Japan, influenza vaccination for the 
elderly 65 years old and older, and 60 years and older in the high-risk group with 
chronic diseases such as diabetes and with cardiac, kidney, and respiratory diseases as 
wel as compromised immune systems, was included in NIP in 2001. 
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Since 1970, the WHO has used the concept of excess mortality from respiratory 
diseases during influenza season, which estimates the total mortality caused by 
influenza (90). Excess mortality is the mortality estimate from influenza during an 
influenza outbreak from among the total death increase of the entire population. Under 
the WHO definition, Assad et al. adopted excess mortality from respiratory diseases 
(90). However, Takahashi et al. used Japanese data from 1987 to 2005 and noticed that 
respiratory diseases, cardiovascular and cerebral vascular diseases al increased during 
flu season; they established estimation including these diseases (94). They also 
suggested that 85 to 90 percent of the excess death occured among people 65 years old 
and over. The most frequent cause of deaths are pneumonia and heart diseases folowed 
by cerebral vascular diseases. The substantial excess mortality of the 2004 to 2005 
influenza season was as many as 15,000 deaths with 80 percent of the mortality from 
the elderly who were 65 years and older (91). Folowing Takahashi’s study, Tachibana 
et al. reported that acute respiratory diseases, ischemic heart diseases and cerebral 
vascular diseases al increased during the flu seasons from 1980 to 1994 in Japan (95). 
In Japan, the National Institute of Infectious Disease publishes the “National Institute 
of Infectious Diseases (NIID) Model” from the 1998-99 season based on stochastic 
frontier estimation, originaly developed in economics by Aigner et al. (1977), Jondrow 
et al. (1982) and Shindo et al.  NID developed this model to estimate the excess 
mortality caused by influenza during influenza season (156). According to this model, 
several thousand excess deaths are reported during recent influenza seasons (Fig.1). 
However, this public health problem does not atract great atention from the public. 
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1.4.3.7 Mumps vaccination 
The WHO recommends including mumps vaccinations in national immunization 
programs in their position papers, but as of 2015, Japan has not done so (5, 39). For 
currently mumps vaccinations, 2 MMR doses have been adopted worldwide and 120 of 
194 WHO member countries provide more than 2 MMR doses while 11 countries 
provide only one MMR dose as of 2014 (21). According to the WHO-UNICEF Joint 
Reporting Form on Immunization (JRF) and WHO statistics reported from regional 
WHO ofices, countries that mandate two doses of mumps vaccines reported almost 
zero cases (7). 
Among 34 OECD member countries, only Japan does not include mumps vaccine 
or MMR in NIP. In nearby Asian countries, Hong Kong-China and the Republic of 
Korea adopt two MMR doses and the People's Republic of China (PRC) one dose (21). 
Due to the widespread of mumps vaccines in the world, reported cases of mumps in the 
world are mainly from the PRC and Japan. 
China reported 479,518 cases; ranking at the top, folowed by Japan’s reported 
71,549 cases in 2013, surpassing the number of cases reported by WHO countries in 
SEAR and AFR (42) (Fig.2).In Japan the estimated immunization rate of mumps 
among eligible children is only about 30 percent, raising public health concerns such as 
increased risk of meningitis, encephalitis and deafness caused by contracting natural 
mumps as many as more than one milion reported cases (4).  
 
1.4.3.8 Seasonal influenza vaccine among the child population 
After the Asian flu (1957) and Hong Kong flu (1968) pandemics, seasonal 
influenza live atenuated vaccine became recommended and school-located vaccination 
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(SLV) became mandatory according to the Preventive Vaccination Law Amendment in 
1976. Every child had the flu vaccine at school (103). 
However, one report tracking the incidence of influenza for five years in Maebashi 
city was published in 1987, contesting the influenza vaccine eficacy. The report 
atracted great atention and the influenza vaccination was withdrawn from NIP in 1994. 
The influenza vaccination rate has continued to drop since then; the estimated seasonal 
influenza vaccination rate among children is around 30 percent (105). 
School children of 5 - 18 years are a primary vector for influenza because they 
have a longer communicable period than adults (134, 177). Hul et al. reported that 
raising vaccination rate among school children could protect elderly population (159). 
In order to achieve herd immunity to protect vulnerable populations like the elderly 
people, it would be necessary to raise the low rate. But this issue has not atracted 
public atention enough. 
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Chronology 1 Events and issues related immunization in Chapter I 
Cont’d to next page
Year Events and issues related immunization
1897 Communicable Diseases Prevention Law
1948 Preventive Immunization Law 
  Smalpox, typhoid fever, diphtheria, tetanus, and acelular pertussis (DPT) 
  vaccination started.
1951 Tuberculosis Prevention Act
 500000 tuberculosis (TB) cases were reported in Japan.
  Bacilus de Calmette-Guerin (BCG) vaccination started.
1957 Asian flu pandemic
1960 Last polio outbreak was reported in Japan.
  6500 cases were reported.
1961 Oral Polio vaccination (OPV) started.
  Vaccine-associated paralytic polio (VAPP) have been reported annualy.
1968 Hong Kong flu pandemic
1976 Rubela-Containing Vaccination (RCV) started only for girls.
Seasonal influenza School-located vaccination (SLV) for children started.
1978 Measles vaccination started.
1989 Measles, mumps and rubela (MMR) combination vaccine was introduced 
in national immunization program (NIP).
Many side efects of aseptic meningitis related MMR was reported.
1993 MMR was withdrawn from NIP.
1994 SLV terminated (Seasonal influenza for children became non-mandatory 
vaccination).
1999 Infectious Diseases Control Law
2000 Measles outbreak worldwide
 
  
33 
 
             Cont’d from previous page
2001 Measles outbreak in Japan 
 286000 cases were reported mainly in babies.
   Due to vaccination rate decline after MMR withdrawal.
Two doses of measles vaccinations started.
Seasonal influenza vaccine for 65 years older with high-risk population for
60-65 was included in NIP.
2004
Seasonal influenza excess death peak
 15000 deaths due to total causes were estimated.
2005 Reported mumps case peak
 1.35 milion cases were estimated.
2006 Preventive Vaccination Law Amendment
MR combination vaccine two dose started.
 12-24 months and 5-7 years population
2007 Measles outbreak in Japan 
 The adult population of two dose system (only one dose population).
2008 Third dose of measles vaccine was temporarily administered.
(13 years old and 18 years old population).
2009 The 2009 H1N1 influenza (Swine flu) pandemic
2012 Rubela outbreak in Japan (adult male population)
  15000 cases of rubela and 32 cases of Congenital Rubela Syndrome
  (CRS) were reported.
Additional rubela vaccine was administered to the male population.
2013 Preventive Vaccine Law Amendment
  Haemophilus influenza type b (Hib), human papilomavirus (HPV) and 
  pediatric streptococcus pneumonia were included in NIP.
Reported measles cases were dropped.
Side efects of HPV vaccine were reported.
2014 Preventive Vaccine Law Amendment
 Chicken pox vaccination was added in NIP
 Seasonal influenza under 65, mumps, rotavirus and hepatitis A and B are not
 included yet.
 Inactivated polio virus vaccine (IPV) was switched with OPV.
Recommendation for HPV vaccine was withdrawn.
19615 TB cases were reported in Japan.
Polio eradicated from African continent.
Note: Not al event and issues related immunization in history are included in this table.
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Figure 1 The excess mortality during the influenza epidemic periods (total 
mortality) Stochastic Frontier Estimation Model 
Infectious Agents Surveilance Report (IASR); National Institute of 
Infectious Diseases (Accessed October 2015) 
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Figure 2 Mumps incidence reported cases；The WHO member countries 
（Data are from World Health Organization. Immunization, WHO Data  
Statistics. Disease incidence. Mumps reported cases, accessed Oct.01, 2015） 
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Chapter I 
 
About the studies in this paper 
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2. 1 Backgrounds and objectives 
The above literature research demonstrates that Japanese immunization has many 
issues to address concerning public health. Mumps vaccination in the child population 
and seasonal influenza vaccination in the elderly population are two issues to be 
prioritized and addressed in Japan, but these issues have not been atracting great 
atention. We must focus on why the vaccination rates are low, considering vaccination 
as a preventive health behavior, and on factors that influence vaccination behavior. 
As mentioned in the literature review, the Health Belief Model (HBM) has been 
proven very efective for exploring individual health behaviors such as being 
vaccinated or not in studies abroad. However, the number of vaccination behavior 
studies based on HBM constructs is stil smal and efective HBM utilization for health 
behavior and promotion studies in Japan is stil litle known and insuficient. 
Under the circumstances, the author decided to choose the above discussed two 
issues of mumps vaccination among children and seasonal influenza vaccination 
among the elderly population 65 years and over. The backgrounds behind these issues 
were examined to investigate why the mumps vaccination rate among the child 
population and the seasonal influenza vaccination rate among the elderly population are 
low. The factors examined include HBM that influences vaccination, focusing on 
vaccination as the common objective in the studies in this dissertation. 
 
2.2 Methodology 
As no national database for non-mandatory immunization was available in Japan, 
two questionnaire surveys were organized, one targeting mothers with children for 
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Study I to investigate mumps vaccination in children and another targeting the elderly 
population for Study II. Study I “Factors Associated with Mothers not Vaccinating 
their Children against Mumps in Japan” was based on a maternal questionnaire survey 
undertaken from 2010 to 2011. Study II “Seasonal flu vaccination acceptance among 
the elderly people who live in a community in Japan” was undertaken in 2009 and in 
2010. 
For both questionnaire surveys, alumni lists obtained from ofices oficialy 
agreed upon were used and a retrospective cross-sectional study was conducted. Along 
with each questionnaire, the author provided a cover leter explaining that study 
participation is completely voluntary and that responding to and returning the 
questionnaire would be regarded as informed consent to participate. 
 
2.2.1 Mixed and triangulation methods 
In the studies in this paper, even though many questionnaires were sent to 
potential participants randomly selected from alumni lists, the number of participants in 
the studies was smaler than expected and the colected data were limited. In order to 
increase the analytical quality of the studies, triangulation method of mixed method 
were adopted. A mixed method is a statistical analytical method where several 
analytical methods such as qualitative and quantitative methods are adopted in the 
same research and data are colected concurently or sequentialy. Research, especialy 
in health and preventive care services, that uses mixed methods has been increasing 
over the past 10 years and wil continue to increase in the future (181, 182). The mixed 
method is utilized in health care research such as examining primary and preventive 
care as wel as in welfare, sociology and behavioral science research (180, 183). The 
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triangulation method classified in the mixed method is to organize qualitative and 
quantitative methods together, colect data concurently and integrate them into a study. 
In the studies in this paper, the two questionnaire surveys included open-ended 
questions where participants freely wrote their opinions to reply to designate questions. 
 
2.2.2 Quantitative analysis 
As quantitative analysis of the studies in this dissertation, first descriptive analysis 
was conducted. Then unadjusted univariate logistic regression analysis was performed 
for participant characteristics and HBM factors including social factors, using 
vaccination and non-vaccination statuses as dependent variables. Participant age was 
regarded as a continuing variable and immunization status was compared with 
Student’s t-test. Other variables were entered into a univariate logistic regression 
analysis using the binary vaccination status of vaccination or non-vaccination as 
dependent variables to obtain unadjusted odds ratios (OR). As a dependent variable 
was not normaly distributed and a binominal category variable was, discriminant 
function analysis was not considered. The author adopted univariate and multivariate 
logistic regression analysis. For variables that did not meet the assumption for the χ2 
test, the p value was obtained by the Fisher Exact Test.  
To improve analytical quality, HBM barrier factor variables of HBM constructs in 
Studies I and II were created by combining the questionnaire results of multiple 
selection responses of reasons for non vaccination and text responses of opinions about 
vaccinations in open-ended questions. A text analytical method was used to create new 
barrier factor variables. 
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2.2.3 Selection of variables for multivariate analysis 
2.2.3.1 Rational for selection method 
Harel et al. suggested that uncritical application of modeling techniques can 
result in models that poorly fit the dataset at hand, or, even more likely, inaccurately 
predict outcomes on new subjects (22, 23). Previous studies suggested that automated 
subset algorithms, which are backward elimination, forward selection, and stepwise 
methods, are sometimes inaccurate, and noise variables are sometimes included in final 
models (160). Selections using these automated methods are afected by the corelation 
between variables and the number of candidate predictor variables, risking very 
important variables being eliminated from final models and noise variables entering (22, 
27, 30). Considering these issues, the limited backward step-down method in 
multivariate analysis was adopted considering al interactions between the variables (22, 
25). 
In variable selection, al statisticaly significant variables (alpha<0.05) and 
noticeable variables, even if they were not significant for univariate analysis, and al 
interaction variables identified by Spearman’s rank correlation tests (r>0.4) were 
candidates for multivariate logistic regression analysis, again using binary vaccination 
status such as vaccination or non-vaccination as the dependent variable. Variables for 
the adjusted analysis were selected with the step-down method by selecting a wide 
range of variables using a liberal p-value of 0.15 by backward elimination stepwise 
variable selection to build a final multivariate model (25).  
As previous studies have suggested, over fiting variables in a multivariate method 
may lead to risking type I errors that may erroneously reject the nul hypothesis, and a 
variable may incorectly have no impact on the outcome. In analogy to type I erors, 
  
41 
 
the analysis may lack the power to detect important variables and so type II errors may 
afect the outcome (26). Accordingly, the number of independent variables in the final 
multivariate model was determined and limited by the outcome number divided by 10 
(23, 26).   
Selected variables were included in a second multivariate analysis to evaluate the 
model’s overal accuracy in predicting vaccination with the Hosmer-Lemeshow 
goodness-of-fit test and the C-statistic, which is the area under the receiver operating 
characteristics curve (23, 24). The results are reported as adjusted odds ratios (aOR) 
with 95 percent confidence intervals (CI). Alpha was set at 0.05, and al tests were two-
tailed; data were analyzed with SPSS Statistics, version 21. 
 
2.3 Ethical review 
The Ofice of Human Research Ethics (Internal Review Board) at Waseda 
University established the Guidelines regarding Academic Research Ethics. In this 
study, the questionnaire was anonymous and data obtained from the questionnaire were 
completely de-identified so that this study did not need to be reviewed by the Internal 
Review Board (185). Papers consisting of parts of this dissertation were accepted by 
journals agreeing with the above mentioned conditions. 
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Chapter II 
 
Study I: Factors associated with mothers not 
vaccinating their children against mumps in Japan 
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3.1 Background and objective 
After MMR's withdrawal in 1993 from NIP due to a reported increase in aseptic 
meningitis, mumps vaccination became voluntary. Single dose vaccines have been 
consistently provided since then and the mumps vaccination coverage rate 
subsequently dropped from almost 90 percent to about 30-50 percent (4, 10, 67, 70). 
This low mumps vaccination rate among eligible children in Japan is a public health 
concern. In 2006, 1.18 milion cases of mumps were reported in Japan (6). According 
to NID, 1.35 milion annual mumps cases were reported in 2005 and curent annual 
estimates are 0.4 to 1 milion cases, with about 60 percent being children between birth 
and six years old and the other 40 percent a large population including adults (6). 
Increasing complications from mumps, including meningitis, encephalitis and 
deafness, are also a public health concern in Japan (8, 9). The corect numbers of these 
complications in Japan are unknown due to lacking a large national database for 
colecting and managing the data, but previous studies reported that 13 out of 1051 
natural mumps cases resulted in meningitis (4) and approximately 1800-2000 natural 
mumps cases caused deafness annualy in Japan (8, 9, 10). Given this low mumps 
coverage rate in Japan, understanding the barriers and factors influencing children’s 
mumps vaccination rates from a wide range of perspectives is necessary. Yet no 
published studies have been conducted to identify determinants for increasing mumps 
vaccinations in Japan. Studies suggest that maternal awareness including health belief 
model factors influences children’s vaccination uptakes (11, 12, 13, 14), but I believe 
other factors are specific to Japan. In Japan, mothers’ taking their children to be 
vaccinated is common. Accordingly, a group of mothers was surveyed to determine 
what factors influenced their decisions to have their children vaccinated, including the 
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change in maternal consciousness from the 1990s when the mumps vaccination rate 
was 90 percent to today where the rate has dropped more than half. 
Considering the low vaccination rate of mumps among children and an increase in 
natural mumps cases, the author determined to study maternal awareness in Study I to 
investigate factors including HBM that influence maternal decisions to have their 
children vaccinated. 
 
3.2 Sample and method 
In this study, a sample of women was selected from Waseda University between 
1980 and 2003. We used alumna lists provided by the alumni ofice at Waseda 
University to conduct a retrospective cross-sectional study using a quantitative and 
qualitative mixed method. We set the target maternal age margin widely because the 
average age for the first birth of Japanese women was 27 years old in 1985 and 30 
years old in 2011 (31); I wanted to research the change in their consciousness after 
MMR termination in 1993. We sent 1268 questionnaires with cover leters by postal 
mail including self-addressed, stamped return envelopes from 2010 to 2011. The cover 
leter explained that the questionnaire was completely anonymous, data obtained from 
the survey would be de-identified and only aggregated data would be used. The cover 
leter also added that participation was voluntary. 
Only participants’ first born children were subject to analysis in these studies. 
 
3.2.1 Instruments 
We developed a questionnaire consisting of 10 demographic questions on the 
respondent and her family and 18 questions regarding vaccinations and vaccination 
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statuses for mumps and other vaccinations such as measles, rubela, poliovirus, DTP, 
Japanese encephalitis, influenza virus type B, pneumococcus, chicken pox and hepatitis 
A and B. We also asked for children's medical histories, subjective wealth and the 
maternal working status when the children were vaccinated. Other questions covered 
HBM factors such as the perceived eficacy of mumps vaccination for their children, 
perceived severity of mumps on their children, cues to the action that encouraged them 
to take their children to be vaccinated, perceived barriers influencing non-vaccination 
for each ilness and who takes their children to be vaccinated. Wiling to pay (WTP) 
was a 5-point scale of less than 1000 yen, 2000 yen, 3000 yen, 4000 yen and over 4000 
yen. We asked concerning the maternal commitment to vaccination in the questionnaire 
as to how mothers think of vaccinations in Japan. They were asked to choose one of the 
folowing responses: a) vaccinations have side efects so they should al be voluntary, 
b) current Japanese vaccinations mainly based on single doses are okay and more 
vaccinations are unnecessary, c) an improved vaccination system is necessary with 
informed consent from parents, d) Japan should adopt a stricter vaccination system 
such as that in the USA. The responses resulted in a maternal commitment to 
vaccination that was divided into a 4-point scale of weak, moderate, strong and very 
strong. We also asked for maternal preferences concerning combination vaccines from 
among a) single doses, b) combination double vaccinations, c) combination triple 
vaccinations and d) quadruple combination vaccinations. In an open-ended question, I 
asked the mothers to write down their opinions of vaccination. 
 
3.2.2 Statistical methods 
According to the statistical analysis described in the methodology in this section, 
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first descriptive statistics analyze participant characteristics, immunization statuses, 
reasons for non-vaccination, HBM constructs, maternal commitment to vaccination and 
maternal preference for combination vaccinations. The age variables of mothers who 
had and had not immunized their children against mumps and of the children were 
compared with Student’s t-test. For the HBM barier variable, barier factors were 
extracted by text analysis of responses from open-ended questions. These barier 
factors were combined with reasons for non-vaccination, creating new HBM barrier 
variables. After descriptive analysis, univariate analysis was performed for each 
variable being an independent variable for non-vaccination of mumps and calculated 
non-adjusted ORs were obtained. For variables that did not meet the assumption for the 
χ2 test, the p value was obtained by the Fisher Exact Test. Univariate analysis was not 
performed for maternal preference constructs because of the similarity of questions 
concerning maternal obligation constructs. 
We also used Spearman's rank correlation tests to analyze al interaction variables. 
Univariate analysis as described in the methodology section used selected variables 
from al candidate variables A final multivariate logistic regression analysis model of 
non-vaccination of mumps as a dependent variable was established by selected 
variables from al candidates variables from univariate analysis using the method 
described in methodology section. 
 
3.3 Results 
In 2010, the author mailed 1268 questionnaires. Of these, 628 (49.5%) were 
returned as undeliverable; of the remaining 640 that were delivered, 226 (35.3%) 
returned the questionnaires. Among 226 respondents, two questionnaires were 
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incomplete, leaving a sample of 224 women (35.0%). This recovery rate (35%) may be 
inevitable because of the low birth rate (TFR: total fertility rate) of 1.39 for Japanese 
women as shown by national demographic data in 2011 of the Ministry of Health, 
Welfare and Labor (31).        
 
3.3.1 Descriptive analysis results 
3.3.1.1 Vaccination status of the participants 
 Table 1 shows a descriptive analysis of al vaccination statuses including NIP and 
non mandatory vaccinations in this population with the national average published by 
NID. The NIP vaccination rates in this population such as polio (96.9%), BCG 
(95.1%), measles (94.2%), DTP1(92.4%) and rubela (88.8%) were as high as expected 
except for DT2 (DTP3[62.9％]), but non-mandatory vaccination rates at the time of the 
survey such as Mumps (61.6%), Varicela (37.5%) and seasonal influenza (41.7%) 
were low compared with NIP rates. Vaccination rates of influenza type b (9.8%), 
hepatitis B (9.8%), pneumococcus (2.2%) and hepatitis A (1.3%) were especialy low 
and many participants responded that they did not know about the vaccines.  
 
3.3.1.2 Characteristics of participants and mumps vaccination status 
Characteristics of participants 
Table 2 shows the descriptive analysis results including mothers’ and children’s 
characteristics; a total of 224 mothers with children participated. The mean (SD) age of 
the 224 mothers responding at the time of this survey was 44.7 (SD=5.02; 30-55 years) 
and the mean age of mothers during the recommended vaccination period was 30.52 
(SD=3.94; 20-43 years). The number of children the participants had was two children 
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(48.7%), one child (31.7%) and three children (17.9%). In responses to who took the 
children to be vaccinated, 204 (90.7%) responded mothers (myself) regardless of their 
age and only 17 (7.6%) responded others. For child characteristics, the mean (SD) age 
of the 224 children was 14.16 (SD=6.71; 0-22>years) and the average age was higher 
than expected. The ratios of males to females were 50.0: 46.5. Those who lived with 
children during the children's vaccination period were mothers and fathers (79.2%), 
others such as grandparents, aunts and uncles (9.7%) and mothers alone (7.1%). In this 
population, 92.4 percent of mothers responded that they took their children by 
themselves to be vaccinated. 
Mumps vaccination status 
Of the 138 (61.1% of 224) children vaccinated for mumps, 47 (34.1%) had the 
MMR vaccination. Among them, 20 had MMR abroad, 14 had MMR from unknown 
sources and 13 appeared to have had MMR before 1993 when it was withdrawn from 
NIP. The remainder had the vaccination as a single dose. The reasons for non-
vaccination of mumps, if any, are shown in Table 3. 
 
3.3.1.3 Maternal commitment and vaccination preferences 
Maternal commitment to vaccinations and maternal preferences for combination 
vaccinations analyzed by descriptive statistics are shown in Table 4. For maternal 
commitment to vaccinations, nearly 63 percent of mothers responded that more 
progressed vaccination system was necessary; however, mothers who thought a strict 
vaccination system like in the US necessary were only 14.2 percent. For responses 
about maternal preferences for combination vaccines, mothers who prefered the 
double combination vaccination were 32.2 percent, folowed by the triple combination 
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vaccination at 28.6 percent, the quadruple combination vaccination at 18.5 percent and 
the single dose at 11.9 percent (Table 5). 
 
3.3.1.4 HBM factors 
According to the method described in the statistical method section, HBM barrier 
variables created by combining reasons for non-vaccination (Table 3) and key words 
extracted from text responses in open-ended questions by text analysis (Table 6) are 
included in Table 7. A number of responders to reasons for non-vaccination question 
and open-ended question was 55 and 139 respectively. 
Table 7 shows the descriptive statistics of HBM constructs. About 9 percent of 
mothers thought the mumps vaccine inefective for their children and about 5 percent 
of mothers did not understand the severity of mumps contracted after maturity. The 
most frequent information source about vaccines (cues to action) was communication 
from local government (61.6%), learning from booklets or brochures obtained (58.5%) 
and checking the maternity handbook (54.9%). The most frequent perceived bariers 
were ofered at inconvenient geographic locations (29.9%), fear of harmful side efects 
(19.9%) and vaccination being expensive (17.4%). About 33 percent of mothers 
responded that they were wiling to pay more than 4000 yen, but 22 percent of mothers 
responded 1000 yen folowed by 2000 yen (21.7%). 
 
3.3.1.5 Social factors 
Table 2 also includes social factors such as areas where the mothers lived during 
the vaccination period for their children. The participants’ residential areas when 
vaccinated were urban (35.7%), rural-adjacent (51.8%) and rural (12.5%); nearly half 
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lived in the Kanto Area. The participants who lived abroad when the children were 
vaccinated were 8.98 percent, which was probably a higher rate than the average 
population. Subjective life standards when vaccinated were very good (12.0%), good 
(40.6%) and average (39.7%); poor was only 5.8%.  
Focusing on cue to action factors, mothers who received information only through 
non human relationships of non social such as learning from communication from local 
government, booklets or brochures obtained in public places, checking maternal 
handbooks and media were 59 (26.3%) (Table 7). 
 
3.3.2 Univariate analysis results 
3.3.2.1 Characteristics of participants 
Table 1 also contains the results of Student’s t-test for the age characteristics of 
mothers and children, and unadjusted logistic regression analysis for other 
demographic characteristics. From the results of Student’s t-test and univariate analysis, 
children were more likely to be vaccinated for mumps during the vaccination period if 
their mothers were older (p<0.01) or living abroad (OR=0.16; p=0.015） (Fig. 3), and 
less likely if their mothers had three children (OR=2.25; p=0.045) (Fig.4) or were 
living in rural regions (OR=2.86; p=0.049) (Fig.5). Boys were more likely than girls to 
be vaccinated (OR=0.82; p=0.48), although not significantly. For family types, neither 
type afected children’s vaccination status nor with or without support for their children 
for vaccination did not afect children’s vaccination status in this study either.  
 
3.3.2.2 Maternal commitment 
The unadjusted analysis results of maternal commitment to vaccination for 
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predicting non-immunization of mumps are shown in Table 4. From this analysis, 
mothers who think ‘stricter vaccination systems are necessary’ were significantly more 
likely to have their children vaccinated (OR=0.23; p=0.02) (Fig.6). 
 
3.3.2.3 HBM factors 
Table 3 shows Health Belief Model Constructs such as the perceived eficacy of 
mumps vaccination, perceived severity of mumps on their children, cues to action, 
perceived bariers, wilingness to pay (WTP) and results of univariate analysis on non-
vaccination as the dependent variable. From the univariate analysis, children were more 
likely to be vaccinated when mothers had recommendations from doctors (OR=0.53; 
p=0.023) (Fig.7). Moreover, they were less likely to be vaccinated when their mothers 
thought the vaccinations inefective (OR=5.62; p=0.002) (Fig.8), the disease not severe 
(OR=5.08; p=0.018) (Fig.9), the vaccinations not mandatory (OR=2.99; p=0.03) 
(Fig.10), the side efects scary (OR=2.42; p=0.01) (Fig.11) and they were busy 
(OR=2.84; p=0.02) (Fig.12). 
 
3.3.2.4 Social factors 
In this study, children who lived in rural areas were significantly less likely to be 
vaccinated for mumps by the unadjusted model (OR=2.86; p=0.049), but not 
significantly by the adjusted model (aOR=1.55; p=0.09). 
Subjective life standards did not influence vaccination status in this population 
according to univariate analysis (p=0.28-0.72). 
In this study, univariate analysis showed that nonsocial network factors such as 
‘learning from booklets or brochures obtained at hospitals or public places’ (OR=1.16; 
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p=0.59), ‘learning from the media’ (OR=1.44; p=0.27) and ‘communication from 
municipal governments (municipal governments usualy communicate with mothers 
only by postal mail)’ (OR=1.64; p=0.08) raised the odds ratio of non-vaccination, but 
not significantly. If the population was divided into two groups, however, mothers who 
rely on social networks through relationships with others to obtain vaccination 
information and mothers who do not rely on social networks through relationships with 
others to obtain information, the mumps vaccination rate decreased significantly in the 
non social network group (OR=2.21; p=0.01) (Fig. 13). 
 
3.3.3 Multivariate analysis results 
Folowing the methodology described in the methodology section, variables for 
multivariate analysis were selected. As interaction variables (above r=0.4) were also 
candidates for an adjusted logistic regression model, the author tested interactions for 
al variables. 
The candidate variables were maternal age, the residence area being urban, rural-
adjacent or rural, fearing harmful side efects or not, believing the vaccine efective or 
not, the vaccination being mandatory or not, living abroad when vaccination usualy 
occurs or not, the number of children mothers had, perceived severity of mumps on 
their children, recommendation from the family doctor to vaccinate or not, being too 
busy to vaccinate their children and maternal commitment to vaccination (4 point 
scale). The ‘only through non social network factor’ variable was significant after 
univariate analysis, but excluded from the candidate variables because this variable was 
not independent of other social network factors. From similar reason maternal age and 
children’s age were highly dependent each other and according to the method in the 
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methodology section, the estimated number of variables in a final multivariate analysis 
was mothers reported having non-vaccinated children (n=86) divided by ten equaling 
around 8.6. To avoid over-fiting the model, only maternal age was included in the 
candidate variables. The process and result of step-down variable selection method are 
shown in Table 8. ‘The number of children mothers had’ variable that was not 
significant in the multivariate model was also excluded for the same reason to avoid 
over fiting. Among al interaction variable, child age and maternal age was interacted, 
but only maternal age was selected a candidate so that this interaction variable was 
excluded for candidates. 
As a result, the variables selected for the final adjusted multivariate analysis were 
maternal age, recommendation from the family doctor to vaccinate or not, living 
abroad when vaccination usualy occurs or not, maternal commitment to vaccination (4 
point scale), being too busy to vaccinate their children or not, the vaccination being 
mandatory or not, fearing harmful side efects or not, believing the vaccine efective or 
not and the area of residence being urban, rural-adjacent or rural. The multivariate 
analysis result was shown in Table 9. 
This result has shown that mothers who thought the vaccine was inefective 
(aOR=6.21; p<0.01), who knew that the vaccination was not mandatory (aOR=3.30; 
p<0.01), who feared harmful side efects (aOR=2.55; p=0.03) and who reported being 
too busy to vaccinate their children (aOR=3.30; p=0.02) were significantly less likely 
to have their children vaccinated. Moreover, mothers who were older (aOR=0.91; 
p<0.01), living abroad when vaccination occured or not (aOR=0.10; p=0.02) and cue 
to action factors of the recommendation from the family doctor (aOR=0.35; p<0.01) 
became significant. Mothers who had more commitment to vaccination were more 
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likely to have their children vaccinated and those who lived in more rural areas were 
less likely to have their children vaccinated, but both were not significant (Table 5). 
 
3.4. Discussion 
3.4.1 Maternal and child characteristics 
In this study, maternal age became significant after adjusted analysis and older 
mothers were more likely to have their children vaccinated against mumps. This is 
partially because the average age of this population was high and older mothers (n=13) 
who appeared to have had their children vaccinated against mumps before the MMR 
was withdrawn from NIP were included in this population. Children who lived abroad 
were more likely to be vaccinated, presumably because many countries have stricter 
vaccination requirements before children go to kindergarten or school than Japan (35) 
and parents living abroad might have been more likely to be aware of the need for 
vaccinations. One mother wrote as folows: 
“We were thoroughly informed that we should have our children vaccinated when 
we lived overseas. The knowledge is not wel communicated in Japan and the intake 
has not been enough.” 
 Previous studies have shown that maternal employment can be associated with 
lower childhood vaccination rates (46, 172, 173). In this study, 61.6 percent of mothers 
were not working during their children’s vaccination period, and maternal employment 
did not significantly afect vaccination in the unadjusted analysis. This is because there 
were two groups. One found working and taking their children to be vaccinated 
dificult; the other thought vaccination was efective for them to avoid taking sick-
leave to care for their children. One of the former wrote: “Vaccinations were not 
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available on holidays so that I had to take a day of to have my children vaccinated, 
which was very annoying.” One of the later wrote: “I worked and it was dificult to 
take of days when children got sick so that my children got vaccinations for VPDs as 
much as possible.”  
For the number of children factor, some Japanese studies suggest that the number 
of children in one family afects the vaccination rates for their children (13) or that 
when mothers have many children, vaccination incompletion risk increases (173). In 
our study, mothers with three children became significant by unadjusted analysis. 
Mothers with more than one child commented on the dificulty, writing as folows: 
“It was hard to wait for a long time with two children at the hospital.” 
“It was hard to travel some distance with the children to get their shots.” 
Mothers stil usualy take their children to be vaccinated by themselves in Japan, 
which may be a strong barrier against smal children being vaccinated and raises 
another concern. 
 
3.4.2 Maternal awareness and HBM factors 
Parental health beliefs, especialy maternal vaccination awareness, influence the 
decision to vaccinate children (44, 45, 46). HBM constructs are a very efective tool to 
analyze or predict vaccination behaviors abroad, including maternal awareness. Brewer 
et al. reported in their meta-analysis (N=15, 988) that risk perception, severity and 
susceptibility were an efective tools to predict vaccination behavior (137). HBM 
vaccination studies in Japan are stil few in number, but some studies show HBM 
constructs to influence vaccination rates (138). In addition, the perceived cost barrier 
reduced maternal awareness for Hib vaccine uptake (13). Supporting this conclusion, 
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mothers who did not perceive the eficacy of mumps vaccination in adjusted models 
and who did not perceive the severity of mumps for their children in an unadjusted 
model were shown to be significant in this study. Some mothers thought mumps 
vaccine was inefective and that natural immunity was beter to acquire immunity. 
They wrote: 
“Contracting mumps for acquiring immunity was more effective.”  
“I do not trust vaccinations at al. Natural immunity or hygiene is more important 
to prevent communicable diseases.” 
Orchitis among boys is a beter-known risk among the complications caused by 
natural mumps; correct knowledge of complications such as increasing risks of 
meningitis or deafness wil have to be disseminated. 
One cue to action factor, recommendations from family doctors, is known to be a 
significant predictor for vaccination uptake elsewhere (35, 44, 49, 59, 133,135). Brown 
et al. reported that the maternal relationship with their health professionals 
diferentiated between MMR acceptors and rejecters in many cases (49). In our study, 
recommendations from family doctors significantly predicted positive vaccination 
uptakes by both unadjusted and adjusted analysis. One mother commented as folows: 
“It was dificult to obtain information about non-mandatory vaccination and the 
family doctor’s advice was very helpful.”Another mother, however, was unhappy with 
the information from her doctor and commented: “I do not believe in vaccinations. 
Doctors do not provide enough information.” This suggests that if doctors do not 
provide information, mothers may avoid vaccinations. Bonanni et al. suggested that 
that family doctor advice significantly influenced maternal vaccination uptakes and that 
the GP’s knowledge level influences the recommendation levels (44). 
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Another cue to action factor, knowing of government vaccine subsidies, decreased 
non-vaccination significantly by unadjusted analysis. One mother commented: “Non-
mandatory vaccinations are about 10,000 yen and very expensive. Why don’t 
governments provide more subsidies?” 
Curently, parents have to pay between ¥5,000 to 8,000 (US$50-80) for mumps 
vaccination. Only 61 of 1,727 municipalities subsidized mumps immunization in 2010, 
and at most, only 15 provide a subsidy large enough to cover the cost of the vaccination 
(60, 61). This low subsidy rate by local governments may explain the low mumps 
vaccination rate in Japan. Endo et al. researched a municipality that provided a subsidy 
for mumps vaccination with a high acceptance ratio and suggested that the subsidy was 
efective for raising the vaccination rate (169). 
 For barrier factors, mothers who chose being busy in this study as a perceived 
barrier were less likely to have had their children vaccinated. 
In our study, maternal working status did not afect mumps vaccine uptakes, but 
the barrier factor of maternal busyness was significant after adjusted analysis 
irrespective of maternal working status. One mother wrote: “I have to wait in long lines 
in hospitals with children to have them vaccinated, which is always annoying.” 
 Japan has universal insurance that enables Japanese to access medical care, but 
hospitals are commonly crowded and patients wait for a long time to see doctors. Also, 
only physicians are alowed to provide vaccinations under Japanese law, which may 
cause mothers to wait for a long time. To raise the vaccination rates, ameliorating the 
environment for busy mothers such as introducing combination vaccines to have their 
children vaccinated is necessary. 
Among other barrier factors, ‘the shot is not mandatory’ was a significant barrier 
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to children’s vaccination. Some mothers decided not to have mandatory vaccinations 
for their children and one mother commented: “I did not get mandatory immunizations 
for my children because I am busy and they were expensive.” Bonanni et al. reported in 
their study in Italy that non-mandatory vaccination rates are dramaticaly lower than 
mandatory ones and maternal awareness especialy afects non-mandatory vaccinations 
uptakes (44), which is concordant with this study as shown in Table 1. 
Another barier factor, fear of harmful side efects, was a significant predictor of 
non-vaccination in the adjusted model in our study. One mother commented: “Doctors 
did not explain about vaccination side efects because doctors are always busy.” This 
lack of knowledge may have led to maternal fear of side efects as a barier for children 
to be vaccinated: “When I asked doctors about the side efects, they said that mothers 
had to decide for children to have the shot or not. I do not have enough knowledge so 
that I did not have my children vaccinated.” Cheung et al. suggested in their influenza 
vaccination study of parental population that mothers with higher education were more 
prone to wory about side efects of vaccine than mothers who were lower education 
(134). The participants of study I in this paper were al with higher education of 
university graduates so that it is suggested that fear of side efects may not be 
associated with education levels of parents, but this needs to be studied further. 
Endo et al. suggested that there was no influence of fear concerning side efects 
for the mumps vaccination uptake in their study and concluded that the MMR 
withdrawal issue in 1993 described in Chapter I had no efect on maternal awareness 
(172). However, their subject maternal age was young and their study was a non-
adjusted study with potential confounding factors so that it may be early to conclude 
that.  Brown et al. reported in their study in UK that one paper reported that MMR 
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vaccine caused autism increased rejection of MMR which had afected more than 10 
years (49). 
In our study, some mothers commented as folows: “I remember the withdrawal of 
MMR due to side efects. I need more information” or “MMR was withdrawn during 
my first child’s vaccination period. The side efects are scary, but I let our children be 
imunized due to a sense of obligation.” In our study it was shown that this predictor, 
the post-vaccination aseptic meningitis and withdrawal of MMR in 1993 discussed 
above, may have influenced the maternal awareness that led to the current low 
vaccination rate. 
 
3.4.3 Social factors 
Many studies have reported that residential areas and socioeconomic factors afect 
health care utilization, including vaccination rates (51-54). In this study, children who 
lived in rural areas were significantly less likely to be vaccinated by the unadjusted 
model, which supported the previous study. 
One Japanese study reported that household income afected Hib vaccination 
uptake (13); vaccination was non-mandatory at the time of survey. However, subjective 
life standards were not significant predictors in our study, which may have been due to 
population bias because respondents who had children who ‘lived in rural areas when 
vaccinated’ and who identified as poor were only 12.4 percent and 6.2 percent. 
However, considering some mothers commented that non-mandatory vaccines were 
expensive, the cost issue is relevant. 
Social network factors also influence vaccination rates as one of healthcare 
utilization. These previous findings reported that social networks beter predict parental 
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especialy mothers choice of vaccination choices and messages transmited by 
interpersonal networks strongly influence motivation to obtain vaccinations (62, 63, 
64,132). Marsh et al. reported that message framing strategy by interpersonal 
relationship was efective to raise maternal awareness (63). 
In this study, children of mothers who did not rely on relationships with others to 
obtain information about vaccinations were significantly less vaccinated by univariate 
analysis. The raised odds ratio may suggest that children of mothers with less-extensive 
social networks and poorer communication skils wil be less likely to have their 
children vaccinated. This supports the findings of previous studies and the theory of 
Cohen et al. and Putnam described in the introduction. A further study concentrating on 
social networks including social capital wil be necessary. 
 
3.4.4 Safety of vaccines 
Curently MMRI, containing the Jeryl Lynn strain is widely used worldwide and 
more than 400 milion doses of MMRI have been used in 72 countries as combination 
vaccines (73). The incidence of aseptic meningitis from the MMRI is very low (74, 75, 
76, 77, 78, 79). 
In Japan, the MMRI vaccine is not oficialy authorized yet. The incidence of 
aseptic meningitis of the single dose mumps vaccines curently used in Japan are 
estimated to be 400 in 1 milion doses that are not as low as expected (80, 81).  To 
improve the mumps vaccination rate, a national government subsidy and correct 
vaccine policies are necessary. Also mumps vaccine must be included in NIP. It wil be 
necessary to review the safety of the current mumps vaccinations available in Japan 
and to introduce new and safer vaccines if possible. 
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It may be more atributable to the lack of a national government subsidy and 
policies that are unaware of the importance of mumps vaccination (43).  
 
3.5. Conclusion 
My paper support several conclusions. First the potential HBM on vaccination 
behavior was determined. In this study, factors associated with mothers not vaccinating 
their children against mumps were the fear of harmful side efects, the vaccination not 
being mandatory, the belief that the vaccine was not efective and being too busy to 
have their children vaccinated. Stil, recommendations from family physicians to have 
children vaccinated could have been associated with reduced non-vaccination risk in 
this study. Given these conclusions and the absence of mandatory vaccinations, the 
author can provide a conclusion to raise the vaccination rate at the individual level. In 
addition, going beyond individual education for health behavior change and a public 
education campaign about mumps to also address social and political change such as 
institutional and policy change from ecological model perspectives could help review 
the curent mumps vaccinations available in Japan. Introducing new and safe vaccines 
would be necessary. 
 
3.6. Study limitations 
The study was a cross-sectional study with a population of 224 mothers who were 
university graduates. According to published data from Ministry of Education, Cultural, 
Sports, Science and Technology Japan, the recent ratio of women who graduated from 
universities including coleges and graduate schools is 56 percent. However this 
excludes women who go to universities in their later life. That means that this research 
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population cover majority of education levels in Japan but it may be necessary to 
conduct an additional longitudinal study targeting a wide range of the population of 
mothers with difering education levels to generalize the results obtained here.  
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Table 1 Vaccination rate in this population (N=224) 
 
National average
Vaccine n % as of 2011
Measles           Yes 211 94.2 94
No 13 5.8
Rubela            Yes 199 88.8 94
          No 25 11.2
BCG             Yes 213 95.1 94
No 8 3.6
Polio             Yes 217 96.9 96
No 6 2.7
DTP1             Yes 207 92.4 99 a
No 9 4.0
 DT2 (DTP3)        Yes 141 62.9 102 a
No 77 34.4
Mumps            Yes 138 61.6 30-50 b
No 86 38.4
Chicken Pox        Yes 84 37.5 30 b
No 130 58.0
Seasonal influenza    Yes 91 41.7 30 b
 (Routine vaccination) No 117 52.2
Hib               Yes 22 9.8 -
No 191 85.3
Pneumococcus      Yes 5 2.2 -
No 202 90.2
Hepatitis           Yes 22 9.8 -
No 190 84.8
Hepatitis A         Yes 3 1.3 -
No 209 93.3
DPT (diphtheria, and tetanus toxoids and, acelular pertussis)
DPT1 denotes percentage of population who completed 1st dose of DPT.
DT2 (diphtheria, acelular pertussis)
Total % is not necessarily 100% due to missing values.
National average for NIP vaccines were published data from the National Institute of 
  Infectious Diseases as of 2011.
a Data are overestimated due to duplicating reporting.
b The rate is an estimate from literatures due to a lack of national database.
Pneumococcus, Influenza type b, Hepatitis B were excluded due to low number of
  children who took these vaccinations. 
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Table 2 Demographic characteristics of mother and child and mumps vaccination status 
(N=224) 
 
 
Unadjusted OR
Yes No     (95%CI) p value
Mother characteristic 
Age (Ave.±SD) 45.45±4.96 43.60±4.95  (0.49 - 3.20) <0.01 ** a
 30-40 23 (54.8) 19 (45.2) 1
 41-50 99 (62.7) 59 (37.3) 0.70 (0.35-1.40) 0.31 †
 51-60 14 (66.7) 7 (33.3) 0.58 (0.20-1.73) 0.33 †
Maternal age during recommended vaccination period
 Age (Ave.±SD)  (-0.43-1.73) <0.01 ** a
 20-28 44 (58.7) 31 (41.3) 1
 29-35 69 (59.5) 47 (40.5) 0.97 (0.54-1.75) 0.91 †
 36-42 19 (73.0) 7 (27.0) 0.42 (0.15-1.18) 0.1 †
Maternal working status when vaccinated
 Yes 43 (54.4) 36 (45.6) 1.69 (0.96-2.97) 0.07 †
 No 90 (65.7) 47 (34.3) 1
Residential area when vaccinated
 Urban 57 (71.3) 23 (28.7) 1
 Rural-adjacent 68 (58.6) 48 (41.4)  1.75 (0.95-3.22) 0.07 †
 Rural 13 (50) 13 (50) 　2.86 (1.12-6.94) 0.049  * †
 Prefecture: Tokyo (59, 26.3%), Kanagawa (27, 11.4%), Saitama (7, 3.1%), Chiba (7, 3.1%),
 Others (104, 46.4%)
Subjective life standards when vaccinated 
 Very good 15 (55.6) 12 (44.4) 1
 Good 61 (67.0) 30 (33.0)  0.62 (0.26-1.48) 0.28 †
 Average 53 (59.6) 36 (40.4)  0.85 (0.36-2.03) 0.71 †
 Poor 8 (66.7) 5 (33.3)  0.63 (0.15-2.59) 0.52 †
Living abroad when vaccinated
 Yes 18 (90) 2 (10)   0.16 (0.04-0.70) 0.015 * †
 No 120 (58.8) 84 (41.2) 1
Number of children
 One child 46 (64.8) 25 (35.2) 1
 Two children 71 (65.1) 38 (34.9)  0.99 (0.53-1.84) 0.96 †
 Three children 18 (45) 22 (55)  2.25 (1.02-4.96) 0.045 * †
 Four children 2 (66.7) 1 (33.3) 0.56 b
Child characteristics 
Age (Ave.±SD) 14.65±6.80 13.36±6.54   (-0.53 - 3.12) 0.16 a
  0-1yrs 5 (50) 5 (50) 1
  2-5 yrs 9 (60) 6 (40)  0.67 (0.13-3.35) 0.62 †
  6-10 yrs 26 (66.7) 13 (33.3)  0.50 (0.12-2.04) 0.33 †
  11-20 yrs 65 (56.5) 50 (43.5)  0.77 (0.21-2.80) 0.69 †
  >20 yrs 31 (73.8) 11 (26.2)  0.36 (0.09-1.47) 0.15 †
Sex            
 Male        73 (52.9) 40 (35.4) 0.82 (0.48-1.41) 0.48 †
 Female 62 (44.9) 43 (41.0) 1
 Unknown 3 (2.2) 3 (3.5)
Cont'd to next page
 21 (9.4)
30.52±3.94
75 (33.5) 
116 (51.8) 
26 (11.6) 
Mumps Vaccination
           n (%)           
44.67±5.02
42 (18.6)
158 (70.5)
15 (6.6)
39 (17.3)
115 (50.9)
42 (18.6)
113 (50.0)
105 (46.5)
109 (48.7)
40 (17.9)
3 (1.3)
14.16 ±6.71
10 (4.4)
6 (3.5)
71 (31.7)
79 (35.3)
138 (61.6)
91 (40.6)
89 (39.7)
13 (5.8)
20 (8.9)
204 (91.1)
80 (35.7)
116 (51.8)
28 (12.5)
27 (12.1)
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Cont’d from previous page                                 
 
 
 
 
 
 
 
Unadjusted OR
Yes No     (95%CI) p value
Mumps vaccine status
 Yes  
 MMR 
 Single
 No
Those who lived with children during children's vaccination period
  Mothers aｎd fathers 112 (62.6) 67 (37.4) 1
  Mothers only 11 (68.8) 5 (31.3) 1.37 (0.46-4.08) 0.58 †
  Others 12 (54.5) 10 (45.5) 1.42 (0.59-3.46) 0.44 †
Those who took children to vaccinations
  Mother 78 (38.2） 126 (61.8） 0.82 (0.33-2.02） 0.66 †
  Others 6 (35.3） 11 (64.7） 1
　　 Father (2), Mother or father (6), Grand parents (3), Mother or grand parents (6)
** denote significance of p value is less than 0.01.
*  denote significance of p value is less than 0.05.
a. p value and 95%CI were obtained by student t test for mother's age and children's age. 
b. p value was obtained by Fisher Exact Test due to assumption for χ2 test was unmet.
†. Unadjusted ORs were obtained from univariate logistic regression analysis
of dependent variable as non vaccination of mumps.
Total % is not necessarily 100% due to missing values.
179(79.2)
16 (7.1)
         n (%)           
138 (61.6)
47 (34.1)
91 (65.9)
86 (38.4)
22 (9.7) 
204 (90.7）
17 (7.6）
Mumps Vaccination
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Table 3 Reasons for non-vaccination of mumps (Multiple choice) (N=224, n=86 
Res=55) 
 
 
 
 
 
 
 
 
ｎ ％
Ofered at inconvenience in geographic location 27 12.1
Fear of harmful side efects 25 11.2
The vaccination is non-mandatory 23 10.3
The shot is expensive 16 7.1
The system is complicated 15 6.7
The vaccine is not efective 15 6.7
Being busy 14 6.3
I don't know mumps vaccine 8 3.6
143
Reasons
Total
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Table 4 Maternal commitment to vaccination (N=224) 
 
 
 
 
 
 
 
 
p
 Vaccination should be al voluntary 17 (7.5)
 Prefer current vaccination system  28 (12.5) p=0.57
 Prefer more progressed vaccination system 141 (62.9) p=0.07
 Prefer most strict vaccination system such  32 (14.2) p=0.02*
   that in the USA is necessary
** denote significance of p value is less than 0.01.
*  denote significance of p value is less than 0.05.
unadjusted ORs were obtained from univariate logistic regression analysis of dependent 
variable as non vaccination of mumps.
Total % is not necessarily 100% due to missing values.
Mother's commitment 
0.23 (0.07-0.82)
unadjusted 
OR(95%CI)
1
0.70 (0.21-2.37)
0.40 (0.14-1.10)
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Table 5 Maternal preference to vaccination system (N=224) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preference n (%)
 Prefer single injection system  27 (11.9)
 Prefer double combination vaccination system  73 (32.2)
 Prefer triple combination vaccination system  65 (28.6)
 Prefer quaduple combination vaccination system  42 (18.5)
n is a number of mothers
** denote significance of p value is less than 0.01.
*  denote significance of p value is less than 0.05.
Total % is not necessarily 100% due to missing values.
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Table 6 Barier keywords extracted from open-ended question about vaccination by text 
analysis (N=224, n=139) 
 
 
 
  
 
 
 
 
ｎ ％
Busy (no time etc.) 28 12.3
Expensive (Subsidy need etc.) 24 10.6
Side efect, Safety (worry, scary etc.) 24 10.6
Information (scarce, scarcity etc.) 20 8.9
System, Schedule (complicated etc.) 16 7.0
Natural immunity (contract mumps, etc.) 12 8.6
Inconvenient, access (long distance, bad, etc.) 10 4.4
Waiting time (long, etc.) 10 7.2
Knowledge (need, more, etc.) 8 3.5
Eficacy (not efective, doubtful, etc.) 7 3.1
Total 159
Keywords
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Table 7 Health Belief Model factors and mumps vaccination status (N=224) 
Unadjusted OR
  n (%)           Yes No     (95%CI) p value
Perceived eficacy of mumps vaccine to their children
  Do you think the vaccine is efective to your children?
    Yes 204 (90.3) 133 (65.2) 71 (34.8) 1
No 20 (8.8) 5 (25.0) 15 (75.0)5.62 (1.96-16.10) 0.002 ** †
Perceived severity of mumps to their children
  Do you think the disease is severe to your children when they are contracted?
Yes 212 (93.8) 130 (62.5) 78 (37.5) 1
No 12 (5.4) 7 (58.3) 5 (42.6) 5.03 (1.4-19.07) 0.018 * †
 Cue to the action
  Recommendation from family doctor
Yes 99 (44.2) 72 (72.7) 27 (27.3) 0.53 (0.30-0.91) 0.023 * †
No 125 (55.8) 66 (52.8) 59 (47.2) 1
  Knowing subsidy to the vaccine
Yes 10 (4.5) 9 (90) 1 (10.0) 0.093 a
No 214 (95.5) 129 (60.3) 85 (39.7)
  Learning from experienced mother's recommendation
Yes 37 (16.5) 23 (62.2) 14 (37.8) 0.91 (0.44-1.88) 0.8 †
No 187 (83.5) 115 (61.5) 72 (38.5) 1
  Learning from friends
Yes 60 (26.8) 40 (66.7) 20 (33.3) 0.62 (0.33-1.16) 0.14 †
No 164 (73.2) 98 (59.8) 66 (40.2) 1
  Communication from local government
Yes 138 (61.1) 79 (57.2) 59 (42.8) 1.64 (0.94-2.88) 0.084 †
No 86 (38.4) 59 (68.6) 27 (31.4) 1
  Baby's physical examination
Yes 68 (30.4) 41 (60.3) 27 (39.7)0.998 (0.56-1.79) 0.996 †
No 156 (69.6) 97 (62.2) 59 (37.8) 1
  Leaning from kindergarten or daycare
Yes 31 (13.8) 20 (64.5) 11 (35.5) 0.66 (0.31-1.42) 0.29 †
No 193 (86.2) 118 (61.1) 75 (38.9) 1
  Leaning from booklets or brochures obtained at hospitals or public places
Yes 131 (58.5) 77 (58.8) 54 (41.2) 1.16 (0.67-2.00) 0.59 †
No  93 (41.5) 61 (65.6) 32 (34.4) 1
  Learning from media (Magazine, TV)
  Yes  47 (21.8) 26 (55.3) 21 (44.7) 1.44 (0.76-2.76) 0.27 †
No 177 (79.0) 112 (63.3) 65 (36.7) 1
  Checking maternity handbook
Yes 123 (54.4) 76 (61.8) 47 (38.3) 0.99 (0.58-1.71) 0.97 †
No 101 (44.7) 62 (61.4) 39 (38.6) 1
  Only through non social network information source b
Yes 59 (26.3) 28 (47.5) 31 (52.5) 2.21 (1.21-4.05) 0.01 * †
No 165 (73.7) 110 (66.7) 55 (33.3) 1
Cont'd to next page
Mumps Vaccination
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Cont’d from previous page 
Unadjusted OR
  n (%)           Yes No   (95%CI) p value
Perceived barriers
  The vaccination is not mandatory
Yes 38 (16.8) 15 (39.5) 23 (38) 2.99 (1.46-6.14) 0.03 * †
No 186 (82.3) 123 (66.1) 63 (33.9) 1
  Fear of harmful side efects
Yes 45 (19.9) 19 (43.2) 25 (56.8) 2.42 (1.24-4.70) 0.01 * †
No 179 (79.2) 119 (66.5) 60 (33.5) 1
  Being busy
Yes 24 (10.6) 10 (41.7) 14 (58.3) 2.84 (1.18-6.81) 0.02 * †
No 200 (88.5) 128 (64) 72 (36) 1
  Ofered at inconvenience in geographic location
Yes 67 (29.9) 40 (59.7) 27 (40.3) 1.12 (0.62-2.01) 0.07 †
No 157 (70.1) 98 (62.4) 59 (37.6) 1
  The system is complicated
Yes 35 (15.5) 20 (57.1) 15 (42.86) 1.26 (0.61-2.63) 0.53 †
No 189 (84.4) 118 (63.30) 70 (37.7) 1
  The vaccination is expensive
Yes 39 (17.3) 23 (59.0) 16 (41.0) 1.14 (0.57-2.31) 0.71 †
No 185 (81.9) 115 (62.2) 70 (37.8) 1
　　Long waiting time at hospital
Yes 10 (4.5) 5 (50.0) 5 (50.0) 0.51 a
No 213 (95.5) 133 (62.4) 80 (37.6)
　　Information is scarce
Yes 20 (9.0) 13 (65.0) 7 (35.0) 0.86 (0.33-2.26) 0.76 †
No 203 (91.0) 125 (61.6) 78 (38.4) 1
 Wiling to pay
  1000 yen 50 (22.1) ‡ 28 (56.0) 22 (44.0) 1
  2000 yen 49 (21.7) ‡ 32 (65.3) 17 (34.7) 0.65 (0.31-1.35) 0.25 †
  3000 yen 44 (19.5) ‡ 31 (70.5) 13 (29.5) 0.88 (0.41-1.85) 0.73 †
  4000 yen  3 (1.3) ‡ 1 (33.3) 2 (66.7) 1.01 (0.46-2.18) 0.99 †
  >4000 yen 74 (32.7) ‡ 45 (61.1) 28 (37.83) 1.15 (0.99-13.27)0.91 †
** denote p value is less than 0.01.
*  denote p value is less than 0.05.
†  Unadjusted ORs were obtained from univariate logistic regression analysis of dependent
   variable as non vaccination of mumps.
a.  p value was obtained by Fisher Exact Test due to assumption for χ2 test was unmet.
‡  Total % is not necessarily 100% due to missing values.
b  Non social = Number of mothers who do not rely on relationships with others to obtain
   information only through; checking maternity handbook, learning from media, leaning from 
   booklets or brochures obtained at hospitals or public places and communication from local 
   government.
Mumps Vaccination
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Table 8 Multivariate analysis variable selection by step-down method 
 
                                           
         Cont’d to
Lower Upper
Mother's age -0.11 0.07 2.36 1 0.12 0.89 0.77 1.03
Residential area 0.33 0.28 1.38 1 0.24 1.39 0.80 2.40
Fear of side effects 1.18 0.46 6.65 1 0.01 3.26 1.33 8.01
Not effective 1.75 0.64 7.38 1 0.01 5.75 1.63 20.31
Not mandatory 1.25 0.45 7.65 1 0.01 3.48 1.44 8.42
Living abroad -2.46 0.98 6.33 1 0.01 0.09 0.01 0.58
Number of children 0.24 0.27 0.83 1 0.36 1.28 0.76 2.16
Perceived severity 0.21 0.72 0.09 1 0.77 1.24 0.30 5.10
Recommendation from family
doctor -0.97 0.37 6.95 1 0.01 0.38 0.18 0.78
Being busy 1.50 0.58 6.77 1 0.01 4.48 1.45 13.88
Maternal obligation -0.27 0.25 1.20 1 0.27 0.76 0.47 1.24
Child's age by Mother's age 0.00 0.00 0.06 1 0.80 1.00 1.00 1.00
Constant 3.69 3.02 1.49 1 0.22 40.14
Mother's age -0.10 0.04 6.62 1 0.01 0.91 0.84 0.98
Residential area 0.33 0.28 1.42 1 0.23 1.39 0.81 2.41
Fear of side effects 1.20 0.46 6.88 1 0.01 3.31 1.35 8.07
Not effective 1.74 0.64 7.33 1 0.01 5.70 1.62 20.12
Not mandatory 1.26 0.45 7.90 1 0.00 3.52 1.46 8.48
Living abroad -2.45 0.98 6.26 1 0.01 0.09 0.01 0.59
Number of children 0.27 0.25 1.20 1 0.27 1.31 0.81 2.13
Perceived severity 0.23 0.72 0.10 1 0.76 1.25 0.30 5.17
Recommendation from family
doctor -0.98 0.37 7.07 1 0.01 0.38 0.18 0.77
Being busy 1.48 0.57 6.74 1 0.01 4.40 1.44 13.47
Maternal obligation -0.27 0.25 1.18 1 0.28 0.76 0.47 1.24
Constant 3.10 1.89 2.68 1 0.10 22.11
Mother's age -0.10 0.04 6.61 1 0.01 0.91 0.85 0.98
Residential area 0.32 0.28 1.34 1 0.25 1.37 0.80 2.36
Fear of side effects 1.21 0.45 7.04 1 0.01 3.34 1.37 8.13
Not effective 1.72 0.64 7.30 1 0.01 5.59 1.60 19.47
Not mandatory 1.26 0.45 7.92 1 0.00 3.53 1.47 8.48
Living abroad -2.44 0.98 6.26 1 0.01 0.09 0.01 0.59
Number of children 0.26 0.24 1.12 1 0.29 1.29 0.80 2.08
Recommendation from family
doctor -0.97 0.37 7.02 1 0.01 0.38 0.18 0.78
Being busy 1.47 0.57 6.70 1 0.01 4.36 1.43 13.30
Maternal obligation -0.28 0.25 1.23 1 0.27 0.76 0.47 1.24
Constant 3.25 1.82 3.18 1 0.07 25.90
Variables in Equations
B SD Wald df
p
value Exp(B)
EXP(B)  95%
Step 1a
Step 2a
Step 3a
 next page  
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         Cont’d from previous page 
 
Lower Upper
Mother's age -0.09 0.04 5.94 1 0.01 0.92 0.85 0.98
Residential area 0.37 0.27 1.85 1 0.17 1.44 0.85 2.45
Fear of side effects 1.19 0.46 6.85 1 0.01 3.30 1.35 8.06
Not effective 1.70 0.63 7.28 1 0.01 5.47 1.59 18.79
Not mandatory 1.26 0.45 7.91 1 0.00 3.51 1.46 8.44
Living abroad -2.43 0.97 6.24 1 0.01 0.09 0.01 0.59
Recommendation from family
doctor -1.00 0.37 7.43 1 0.01 0.37 0.18 0.76
Being busy 1.50 0.57 6.87 1 0.01 4.50 1.46 13.88
Maternal obligation -0.28 0.25 1.27 1 0.26 0.76 0.47 1.23
Constant 3.38 1.81 3.47 1 0.06 29.29
Mother's age -0.09 0.04 6.31 1 0.01 0.91 0.85 0.98
Residential area 0.41 0.27 2.40 1 0.12 1.51 0.90 2.55
Fear of side effects 1.28 0.45 8.07 1 0.00 3.58 1.49 8.63
Not effective 1.74 0.64 7.49 1 0.01 5.71 1.64 19.90
Not mandatory 1.30 0.44 8.54 1 0.00 3.66 1.53 8.72
Living abroad -2.26 0.93 5.94 1 0.01 0.10 0.02 0.64
Recommendation from family
doctor -1.06 0.36 8.51 1 0.00 0.35 0.17 0.71
Being busy 1.46 0.57 6.56 1 0.01 4.29 1.41 13.05
Constant 2.58 1.64 2.46 1 0.12 13.19
Number of children, Perceived severity, Recommendation from family doctor, Recommendation
from family doctor, Maternal obligation, Child's age * Mother's age
Backward elimination stepwise variable selctions was done by setting probability for
stepwise entry 0.15 and removal 0.15 (SPSS Statistics 23)
p
value Exp(B)
EXP(B)  95%
a. Step 1:　Variables in equations; Mother's age, Residential area, Fear of side
Step 4a
Step 5a
B SD Wald df
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Table 9 Multivariate analysis findings for predicting non immunization of 
mumps vaccine (N=224) 
Adjusted OR (95%CI) p value
Mother's age 0.91 (0.85-0.96) <0.01 **
Residential area 1.55 (0.93- 2.61) 0.09
Living abroad when vaccination 0.10 (0.02-0.68) 0.02 *
Maternal commitment 0.72 (0.46-1.15) 0.18
Perceived eficacy of mumps vaccine
  The vaccine is not efective  6.21 (1.85-20.91) <0.01 **
Cue to the action
 Recommendations from family doctors 0.35 (0.17-0.71) <0.01 **
Perceived barriers
 Being busy 3.30 (1.21-9.01) 0.02  *
 The shot is not mandatory 3.30 (1.41-7.72) <0.01 **
 Fear of harmful side efects 2.55 (1.10-5.89) 0.03 *
** denote p value is less than 0.01
*  denote p value is less than 0.05
Adjusted ORs were obtained from multivariate analysis of dependent variable 
as non vaccination of mumps 
Hosmer Lemshaw test, ROC analysis, R2=0.32
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Figure 3 Univariate analysis result of mumps vaccine study: Living abroad when 
vaccinated (N=224) 
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Figure 4 Univariate analysis result of mumps study: Number of children (N=224) 
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Figure 5 Univariate analysis result of mumps study: Residential area when 
vaccinated (N=224) 
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Figure 6 Univariate analysis result of mumps study: Maternal commitment to 
mumps vaccination (N=224) 
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Figure 7 Univariate analysis result of mumps study: Cue to the action; 
Recommendation from family doctors (N=224) 
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Figure 8 Univariate analysis result of mumps study: Perceived eficacy of mumps 
vaccine (N=224) 
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Figure 9 Univariate analysis result of mumps study: Perceived severity of mumps 
(N=224) 
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Figure 10 Univariate analysis result of mumps study: Perceived barriers: mumps 
vaccination is not mandatory (N=224) 
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Figure 11 Univariate analysis result of mumps study: Perceived bariers: fear from 
harmful side efects (N=224) 
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Figure 12 Univariate analysis result of mumps study: Perceived bariers: being busy 
(N=224) 
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Figure 13 Univariate analysis result of mumps study: Cue to the action: information 
obtained only through non social network (N=224) 
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Chapter IV 
 
Study I: Seasonal flu vaccination acceptance 
 
among 
 
the elderly people who live in a community in Japan 
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4.1 Background and objective 
 
In Japan, the number of people dying from influenza is stil increasing; influenza 
causes pneumonia, bronchitis and influenza-related respiratory ilnesses that raise 
excess mortality. The majority of the deceased are the elderly and vulnerable 
populations such as those with chronic diseases. 
Given these circumstances, the Japanese government amended the Preventive 
Vaccination Law in 2001 to include flu vaccinations as routine immunizations for this 
age group. People 65 years old and over can now receive flu vaccinations subsidized by 
their local governments. This caused the government to reconsider influenza 
vaccination among the elderly who were 65 years old and older, and 60 years and older 
in a high-risk group of those who have chronic diseases such as diabetes, cardiac, renal 
and respiratory diseases. They were included in NIP in 2001 by amending the 
Preventive Vaccination Law. Although people 65 years old and over now can receive 
subsidies for flu vaccinations from local governments where they live, the decreased 
vaccination rate did not recover suficiently. The estimated vaccination rate among the 
elderly and vulnerable populations is below 50 percent while that among children is 
approximately 30 percent (195), ranking in the lower range of OECD member 
countries (Fig. 14). For example in the US, the coverage of total population with six 
months and older are reported to be nearly 50 percent (97). Additional concern exists 
that the elderly Japanese who belong to high-risk groups may not receive suficient 
seasonal flu vaccinations. 
Under the circumstances, we must consider the low vaccination rate of seasonal 
influenza vaccination among the elderly population, even though the Japanese 
government included the vaccination in NIP in 2001. Addressing the issue of 
  
90 
 
increasing excess death cases during the flu season, the author determined to study the 
awareness of elderly people 65 years and older to investigate factors including HBM 
with the objective of influencing their decisions to be vaccinated. Another goal in this 
study is to examine the vaccination situation of high-risk groups with chronic diseases. 
The author set two objectives in Study I. 
 
4.2 Sample and method 
The author sent questionnaires in 2009 and 2010 to university graduates 65 years 
old and over who were not institutionalized. The candidates were randomly selected 
from lists obtained from university alumni books separately in 2009 and 2010 from 
alumni ofices that were authorized to provide information on those 65 years and older. 
Unfortunately, less than 10 percent of the alumni were female so female graduates 
were excluded to avoid bias due to gender diference. A total of 1457 questionnaires 
were sent in 2009 and 2010 with cover leters by postal mail including self-addressed 
and stamped return envelopes. The cover leter noted that the questionnaire was 
completely anonymous, data obtained from the survey wil be de-identified and only 
aggregated data wil be used. Also, the leter noted that participation was completely 
voluntary. 
 
4.2.1 Instruments 
The author developed a questionnaire with 30 questions such as demographic 
questions on the respondents and their families and questions regarding seasonal 
influenza vaccinations and vaccination status. It asked their ages, working statuses, 
subjective life standards (very good, good, average, poor), self-rated health (SRH; very 
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good, good, average, poor), regions where they live (urban, rural-adjacent, rural) and 
prefectures, living with family or not (not, with spouse, with spouse and children, with 
spouse, children and grandchildren, other). It also asked their influenza immunization 
status (annual, sometimes, never), a multiple choice question about their reasons, if any, 
for non-vaccination (unnecessary, inefective, expensive, bothersome, fear of side 
efects, being busy, other) and history of flu-like symptoms within the past two years 
(yes, no). In addition, prevention measures against the flu if any such as gargling, 
wearing masks in public, having suficient sleep and good nutrition were included. 
Furthermore, respondent knowledge about flu and cold symptoms (high fever, low-
grade fever, joint or muscle pain, exhaustion, sore throat, sneezing) were asked. The 
questionnaire also asked for current and past medical histories, including strokes, 
hypertension, cardiovascular, liver, galbladder, gastroduodenal diseases, diabetes, 
tuberculosis, asthma and chronic bronchitis, anemia, rheumatism and arthritis, cancer, 
bone fractures, pneumonia, alergies and more. Lifestyle questions of healthy habits 
such as exercise, sports hours per week, measuring weight regularly, measuring blood 
pressure regularly, resting regularly, quiting smoking, quiting drinking and relieving 
stress were included. For social participation and activity questions, groups and 
organizations they are participating in such as elderly clubs, neighborhood associations, 
hobby clubs, fitness and sports related clubs, study and culture clubs, civic activity 
clubs, religious organizations, volunteer organizations and NPOs, commerce and 
industry associations, retiree organizations, alumni clubs and employment center 
services for the elderly were asked about. Questions about activities they participate in 
such as sports, hobbies, community involvement, environmental activities, education 
and culture, work productivity, support activities for the elderly, neighbor security, 
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support activities for children and home care were also asked. The same as in the 
mumps vaccine study, HBM constructs such as perceived flu severity, knowing the 
diference between flu and ordinary colds (yes, no), perceived vulnerability to flu and 
colds, perceived eficacy of influenza vaccine, cue to action factors of the information 
sources (open-ended) asking how participants obtain information about flu vaccinations 
and knowing about flu vaccine subsidies, and WTP (wilingness to pay) were asked 
about. Two open-ended questions where participants could write freely were included; 
one was on their opinions about influenza vaccines and the other was about their 
concerns on health care, policy and the health care system. 
 
4.2.2 Statistical method 
As separate data from independent lists in 2009 and 2010 was colected, the 
goodness of fit test was undertaken to test if diferences existed in participant 
characteristics between the two groups. Then, according to the statistical analysis 
described in the methodology in this section, participant characteristics, seasonal 
influenza immunization statuses, medical histories, health habits and HBM constructs 
were analyzed by descriptive statistics. For analysis, the ‘have never had seasonal flu 
vaccines’ group was defined as a non-vaccination group. Age was considered as a 
continuous variable and the diference between who had and had not been immunized 
with flu vaccines were compared with student’s t-test. SRH was skewed, dividing into 
the ‘bad’ or ‘good’ categorical variable. Other categorical and ordinal variables were 
entered into a univariate logistic regression analysis using non-vaccination as a 
dependent variable to obtain unadjusted odds ratios (OR). The total hours spent on 
sports per week, a total number of medical issues and WTP variables did not fal within 
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normal distribution assumptions so that the p values were obtained by the Mann-
Whitney U test comparing vaccinated and non-vaccinated groups. HBM barrier factors 
were created from one open-ended question on opinions about flu vaccinations by text 
analysis extractions and combined with reasons for non-vaccinations (IBM SPSS Text 
Analytics for Surveys 4.0). The questionnaire had a question about groups and 
organizations being participated in and a question about social activities being 
participated in, but the variables included in the questionnaire were twenty-one and ten 
respectively. Some of them overlapped so that factor analysis was performed to reduce 
the variables (IBM SPSS 23). 
Folowing the methodology, variables for multivariate analysis were selected by 
the step-down method. Significant variables after univariate analysis and interaction 
variables (above r=0.4) were also candidates for an adjusted logistic regression model. 
Interactions for al variables were tested by Spearman’s rank correlation tests and a 
final multivariate model of non-vaccination against the flu as a dependent variable was 
obtained. 
Qualitative analysis was performed on replies to the open-ended question of 
opinions on flu vaccination. Replies to an open-ended question on concerns about 
health care, policy and the health care system were analyzed by text analysis. 
 
4.3 Results 
The author sent 1457 questionnaires in total in 2009 and 2010 and 586 (39.2%) 
were returned. Eight returned questionnaires were incomplete, leaving 578 (167 in 
2009, 411 in 2010) to be included in this study. 
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4.3.1 Goodness of fit test between two populations 
As two independent data sets were colected, first the goodness of fit test was 
undertaken to test for diferences in participant characteristics between the two groups. 
From the results, no diferences existed in participant characteristics between the two 
groups including age (p=0.81), work status (p=0.16), regions where they live (p=0.32), 
living with family or not (p=0.59), subjective life standards (p=0.48), sports hours per 
week (p=0.21), immunization status (p=0.89) and self-rated health (SRH) (p=0.08) 
(Table 10). Given these results, the author combined the two data sets together and 
analyzed them as one aggregated data set. 
 
4.3.2 Descriptive analysis results 
4.3.2.1 Participant characteristics 
The study had a total of 578 participants. Table 11 shows the results of descriptive 
analysis of participant characteristics. The participants’ mean (SD) age was 73.19 
(SD=4.43; 65-93 years). About sixty-two percent of participants responded they were 
living with their spouse and only 4.5 percent of participants responded they were living 
alone. 
Nearly 37 percent were working and about 85 percent responded that their SRH 
was good. About 32 percent of the participants responded that they had contact 
histories of flu-like symptoms within the past two years. 
Medical histories 
Among those who reported their medical history (n=514), the most frequently 
reported were hypertension (28.7%), hay fever (15.7%), cancer (12.8%) and diabetes 
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(10.9%). The total number of medical histories for each participant was zero to two 
(70.1%) folowed by three to five (28.2%). Only one participant reported that he had no 
issues in his medical history to report. Thirty-two percent of the participants had 
medical histories such as respiratory, cardiovascular, diabetes and galbladder disease 
that meant they should be recommended to have flu vaccinations (Table 12). 
For the healthy life style question, 74.9 percent of participants responded that they 
regularly exercised such as walking or playing sports. About 41.6 percent of the 
participants answered they had spent one to five hours per week for sports folowed by 
6 to 10 hours per week (23.8%). About 69.4 percent responded that they had taken 
good nutrition (Table 13). Preventive practices besides vaccinations against flu were 
gargling (70.1%), washing hands (67.8%), good nutrition (58.5%) and having enough 
sleep (56.8%) (Table 14). For knowledge about flu symptoms, they reported high fever 
(92.6%), exhaustion (65.9%), joint or muscle pain (65.2%), sneezing (44.8%), sore 
throats (22.4%) and low-grade fevers (8.3%). They responded that their knowledge of 
cold symptoms was sneezing (79.9%), exhaustion (73.5%), low-grade fever (66.6%), 
sore throats (40.3%), high fevers (31.5%) and joint or muscle pain (29.1%) (Table 15). 
More than 90 percent of the participants responded that high fever was an 
influenza symptom. Many responded that they felt more exhausted when they caught a 
cold (73.5%) than the flu (65.9%); some confusion was observed such that nearly 45 
percent responded sneezing as an influenza symptom when comparing the flu and colds. 
 
4.3.2.2 Influenza vaccination status 
The influenza vaccination statuses of the participants were annualy (46.4%), 
sometimes (18.3%) and never (33.8%) (Table 11 ). Table 16 shows the reasons for non-
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vaccination against the flu. The most frequent reasons for non-vaccination were 
unnecessary (28.8%), inefective (15.7%), burdensome (12.1%) and scared of side 
efects (10.1%).  
Among those who had flu vaccinations (n=379), 91.1 percent reported they had no 
side efects. The most frequently reported side efects were fever (8.3%) and sweling 
at injection sites (3.7%); serious side efects such as the motor or neurological related 
side efects (1.1%) were also reported (Table 17).  
 
4.3.2.3 HBM factors 
Table 18 shows a descriptive analysis of HBM constructs. About 20 percent of the 
participants thought they were vulnerable to the flu or colds and about 30 percent of the 
participants thought flu vaccines were inefective. For perceived severity of flu, nearly 
84 percent of the participants responded that they knew the diference between the flu 
and ordinary colds. 
For the cue to action information sources, the most frequently reported source was 
learning from the media (44.5%), folowed by family doctor recommendations (9.5%), 
friend or family recommendations (2.6%), communication from local governments 
(5.2%) and academic journals or experts’ information (4.5%). The least frequently 
reported was learning from booklets or brochures obtained at hospitals or in public 
places (1.6%). 
As explained in the methodology section, barier variables were created by 
combining reasons for non-vaccination and text responses to open-ended questions that 
were extracted by text analysis (Tables 16 & 19). 
Newly created HBM barrier variables are included in Table 18. For barrier factors, 
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the most frequently reported responses were the vaccination was unnecessary (19.7%), 
fear of harmful side efects (11.8%), information about vaccine scarcity (7.3%), 
vaccination being expensive (5.7%), concern about vaccine scarcity (5.5%) and being 
busy (1.6%). 
 
4.3.2.4 Social factors 
Table 11 also contains the social factors of participants. The residential area was 
urban (71.5%), rural-adjacent (26.1%) and rural (2.4%); more participants were living 
in urban areas. The reported residential prefectures of the participants were Tokyo 
(43%), Kanagawa (12.3%) and other prefectures in the Kanto region (18.3%) that 
concentrated in the Tokyo area and nearby.  
About 36 percent of the participants responded that they were working and more 
than half responded that their subjective life standards were good or very good. This 
ratio demonstrates that this population was biased to beter subjective life standards. 
For self-rated health (SRH), as many as 85.3 percent of the participants responded 
with good; only 14.7 percent responded with poor. 
To focus on the social network factor, those who obtained the information only 
through non social network factors such as learned from communication from local 
governments, booklets or brochures obtained in public places, academic journals or 
experts’ information and learning from the media were aggregated. As a result about 50 
percent of the participants did not rely on information sources from social networks 
(Table 18). 
 For social activities, Table 20 shows the responses to a questionnaire about 
groups and organizations that respondents participated in. The most frequent responses 
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were hobby clubs (36%), folowed by retiree organizations (29.8%). The average 
number of organizations or clubs of those who participated in any were 2.3 per 
respondent. Table 21 shows social activities the respondents participated in. The most 
frequent responses were fitness and sports activities (35.9%), folowed by life and 
environment activities (30.3%). Those who responded none accounted for 14.5 percent. 
 
4.3.2.5 Text analysis of open-ended question about concerns 
Free text responses (n=300) to open-ended question of ‘do you have any concerns 
over health care, policy and the health care system?’ were analyzed by text analysis 
software (Fujitsu Trend Search 2008). Keywords extracted by text analysis and a 
concept mapping figure that demonstrates the relationship between these keywords are 
shown in Table 26 and Fig. 30. 
From the results, nearly 70 percent of respondents replied that they have concerns. 
The top keywords were health care, hospitals, doctors and policy, but flu and flu 
vaccine were noticeably among their top concerns (Table 26). If we look at the concept 
map (Fig. 30), these keywords are connected with the keywords of scarcities, 
government, outbreak and others. 
 
4.3.3 Univariate analysis results 
4.3.3.1 Characteristics of participants 
Table 11 also contains the results of univariate analysis for each demographic 
variable as non-vaccination against the flu to be the independent variable and 
calculated the non-adjusted ORs. From the results, participants were more significantly 
likely to be vaccinated against the flu if they were 75 years and older (OR=0.53; 
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p<0.01) and had flu-like symptoms within the past two years (OR=0.54; p=0.002) (Fig. 
15). The participants who responded that they were working (OR=1.19; p=0.33) were 
less likely to be vaccinated but not significantly. Those who lived alone (OR=1) were 
likely more vaccinated, but were not significant due to the low number of participants 
who reported living alone (4.5%). For medical histories and non vaccination analysis, 
those who had histories of rheumatism, gout or arthritis were significantly less 
vaccinated (OR=5.28; p=0.015) and those who had any medical histories making them 
recommendable for flu vaccinations such as respiratory (OR=0.67; p=0.46), 
cardiovascular (OR=0.57; p=0.08), diabetes (OR=0.81; p=0.46) and galbladder 
(OR=0.57; p=0.40) diseases were more vaccinated but not significantly. For the total 
number of medical histories, the Mann-Whitney U test comparing median ranges 
demonstrated that those who had ‘a number of medical histories’ were more 
significantly likely to have been vaccinated (p=0.015) . 
Tables 13 and 14 contain univariate analysis results of the life style health and 
preventive practices against the flu and non-vaccination analysis respectively. Those 
who responded measuring blood pressure regularly (OR=0.64; p=0.013), quiting 
drinking or decreasing the volume (OR=0.54; p=0.009), gargling (OR=0.50; p<0.01), 
washing hands (OR=0.57; p<0.01) and wearing masks (OR=0.58; p<0.01) were 
significantly more vaccinated. Those who had more sports per week were less 
vaccinated (p=0.045). 
 
4.3.3.2 HBM factors 
Table 18 also includes the results of univariate analysis of HBM factors on non 
vaccination against seasonal influenza as a dependent variable. From the analysis, the 
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factors of perceived vulnerability to the flu or colds (OR=0.27; p<0.001) (Fig. 17), 
perceived flu severity (OR=0.54; p<0.01) (Fig. 18), cues to action; recommendations 
from family doctors (OR=0.23; p=0.001) (Fig. 19), knowing about the vaccination 
subsidies (OR=0.21; p<0.001) (Fig. 20) and communication from local governments 
(OR=0.22; p=0.014) (Fig. 21) significantly decreased non vaccination risk. Perceived 
eficacy (OR=30.04; p<0.01) (Fig. 22), barrier factors such as fear of harmful side 
efects (OR=6.67; p<0.001) (Fig. 23), being busy (p=0.001) (Fig. 24) and vaccination 
being unnecessary (p<0.001) (Fig. 25) significantly increased the non vaccination risk. 
However, the variable of ‘concern over vaccine scarcity’ was shown to not be a barier, 
and those concerned over vaccine scarcity were more vaccinated (Fig. 26) (OR=0.26; 
p=0.013). 
 WTP became significant and those who were wiling to pay were more 
significantly vaccinated with the seasonal influenza vaccine (p<0.001) (Fig. 29). 
 
4.3.3.3 Social factors 
Table 11 also contains results of univariate analysis of social factors for non 
vaccination against seasonal influenza as a dependent variable. Among social factors, 
those who reported SRH as poor were more vaccinated than those who reported good 
and was significant (OR=0.51; p=0.02) (Fig. 16). From the results, those who were 
living in rural adjacent regions（OR=1.35; p=0.14）and those who had lower subjective 
life standards (OR=1.03-1.52； p=0.11-0.97) were less vaccinated, but not significantly. 
For social network factors of cues to action, there was no significant diference 
between those who obtained the information depending on social networks and those 
who obtained the information depending on human relationships (p=0.87).  
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For social activity factors, 12 responses regarding organizations and groups (Table 
20) and ten responses regarding social activities (Table 21) had similarities and 
partialy overlapped so that factor analysis was undertaken and the number of total 
variables was reduced to 10 (IBM SPSS 23). From the correlation results between 
social activity scores after factor analysis and seasonal influenza vaccination status, 
those who participated in a community and security, academics and learning, 
productivity, religion, community and elderly clubs and volunteer activities were more 
vaccinated and those who participated in fitness and sports, hobbies and culture, 
supporting the elderly and commercial activities were less vaccinated but not 
significantly. 
 
4.3.4 Multivariate analysis results 
As explained in the methodology section, variables for multivariate analysis were 
selected. Variables which showed significance and close significance after univariate 
analysis, and interaction variables by correlation test (r>0.4), were the candidate 
variables, but there were no interaction variables that should be considered as candidate 
factors in this study. As a result the candidate variables were participant age, SRH, flu-
like symptoms within the past two years, a history of cardiovascular disease, 
rheumatism/gout or arthritis, a number of medical issues, sports hours per week, HBM 
factors such as perceived vulnerability to the flu or colds, perceived flu severity, 
perceived eficacy of influenza vaccine, cue to action factors of family doctor 
recommendations, knowing about vaccination subsidies, communication from local 
governments, barrier factor of fearing harmful side efects, the vaccination being 
expensive and WTP. The barrier factor of the vaccine being unnecessary was 
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overlapped with the barier factor of the vaccine being inefective (r=0.74) and they 
were not independent of each other. The factor of concern over vaccine scarcity was 
not regarded as a barrier factor so that these factors were excluded from the candidates. 
Also the barier factor of being busy was excluded due to the low number of only one 
event although the variable was significant by univariate analysis. 
As a result, the selected variables for the final model were participant age, a 
history of cardiovascular disease, perceived vulnerability to the flu or colds, perceived 
vaccine eficacy, perceived barriers such as fearing harmful side efects and the 
vaccination being expensive, cue to action factors such as family doctor 
recommendations, knowing about vaccination subsidies and communication from local 
governments. The factor of a history of rheumatism, gout or arthritis that was excluded 
in a previous step was included due to additional space for a number of variables 
(Table 22). The results of multivariate analysis are shown in Table 23.  
This shows that participants who were older (aOR=0.90; p<0.01), with a history of 
cardiovascular diseases (aOR=0.26; p=0.016), perceived vulnerability to the flu or colds 
(aOR=0.13; p<0.001), knew about the vaccination subsidies (aOR=0.21; p<0.001) and 
had the information from communication from local governments (aOR=0.12; p=0.024) 
were significantly more vaccinated. Those who thought the flu vaccine inefective 
(aOR=35.10; p<0.00), with a history of rheumatism, gout or arthritis (aOR=10.90; 
p<0.018), feared harmful side efects (aOR=8.74; p<0.001) and thought the vaccine 
expensive (aOR=7.89; p=0.001) were significantly less likely to have been vaccinated. 
Those who had family doctor recommendations (aOR=0.39; p=0.09) were more likely 
to have been vaccinated but not significantly. 
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4.4 Discussion 
4.4.1 Characteristics of participants 
For the characteristics, those who were older and had flu-like symptoms in the 
past two years were more vaccinated after the multivariate and univariate analyses 
respectively. This result was concordant with previous influenza studies undertaken in 
Japan (138, 171). Participants with more sports hours per week were less vaccinated. 
For the factor of working, the odds ratio for non-vaccination of the working population 
was higher than those not working in this study, but not significantly. Previous studies 
undertaken in Japan showed that seasonal influenza vaccinations were low among the 
healthy and working population (171, 190). Wada et al. reported in their study 
researched in 29-69 years old population that the vaccination rate of this population 
was low at around 25 percent (171). The characteristics analysis from this study 
suggests that those who were healthier and younger, probably working and with more 
sports hours, were less vaccinated. 
 
4.4.1.1 Medical histories 
Those with a history of cardiovascular disease were more vaccinated after 
multivariate analysis. Cardiovascular disease is one of the high-risk diseases that 
results in recommendations that people with it have flu vaccinations. One concern 
revealed in this study is that this high-risk group of participants was not vaccinated 
significantly enough. Wang et al. have shown that flu vaccination is efective for risks 
of morbidity, hospitalization, ICU admissions and mortality in the large-scale high-risk 
population (175). Those with high-risk diseases may not know the efectiveness of flu 
vaccination for reducing these risks. This concern about this high-risk group should be 
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studied and addressed further in the elderly population in Japan. 
Participants with a medical history of rheumatism, gout or arthritis were 
influenced less by vaccination after multivariate analysis. This may be partialy 
influenced by influenza vaccinations stil being made from eggs, resulting in those 
alergic to eggs not being recommended to have the vaccination. 
 In addition, those who with more medical histories were significantly more 
vaccinated after univariate analysis. Yi et al. reported that those with underlying 
diseases were more accepting of the flu vaccination (142). This may be due to their 
often having the chance to communicate with family or their atending doctors urging 
vaccination. Participants with health issues commented as folows: 
“I completely rely on my atending physician. I folow his advice to be vaccinated 
(78 years old).” 
“I have a good accessible atending physician and there is no wory (69 years old).”  
From these comments, physician recommendations may have been efective to 
increase seasonal influenza acceptance in this population with diseases. 
 
4.4.1.2 Other preventive measures 
People who have been vaccinated against seasonal influenza folowed other 
preventive measures than flu vaccination such as gargling and wearing facemasks. 
Similarly, a previous study has shown that those who took a preventive measure 
against the flu used other preventive measures (191). Gargling and wearing facemasks 
are common customs in Asian countries. Their efectiveness for influenza prevention 
are stil controversial but Wada et al. suggested that using several preventive measures 
including vaccination against the flu may be efective for influenza protection. 
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4.4.2 Participant awareness and HBM factors 
Similar to the results for Study I, HBM factors became significant after 
multivariate analysis. Vaccination behavior analysis based on HBM factors has been 
demonstrated to be efective in this study, too. 
 
4.4.2.1 Perceived risk 
Risk perception is a critical factor in health behavior theory. In this study, two risk 
perception factors, perceived severity after univariate analysis and perceived 
vulnerability after multivariate analysis, are significant. 
Brewer et al. have shown in meta-analysis (N=15,988) that perceived severity and 
susceptibility (vulnerability) are rigidly reliable risk perception factors that influence 
vaccination increases (137). The number of HBM studies is insuficient in Japan, but 
Yi et al. have suggested that perceived susceptibility significantly raised the influenza 
vaccination rate in the Japanese adult population (142). Iwashita et al. reported 
perceived vulnerability and severity raised maternal awareness to vaccinate children 
with Hib vaccine (13). From this, if risk perceptions are utilized more efectively, 
raising awareness and the vaccination rate in the elderly population in Japan is possible. 
Perceived (non) eficacy 
Disbelief or when people think the vaccine is inefective significantly hinders 
people from having the vaccination (54, 59, 138, 139). In this study, nearly 30 percent 
of participants responded that seasonal flu vaccine is inefective, believing the flu 
vaccine unnecessary (r=0.74; p<0.001). Ciblak et al. have shown in their study in 
Turkey that disbelief in flu vaccine efectiveness greatly decreases flu vaccine 
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acceptance, even in high-risk groups (174). One concern revealed in this study was that 
those with high-risk diseases were also not suficiently vaccinated against the flu 
vaccination and thought flu vaccination inefective too. They commented as folows: 
“I doubt the eficacy of flu vaccine because the influenza virus changes every year. 
Does it realy work for prevention (67 years old, high-risk group)?” 
“Flu vaccination is inefective. I don’t do anything against influenza. If I contract 
the flu, that wil be my fate (77 years old, high-risk group).” 
Seasonal influenza vaccination efectiveness has been controversial elsewhere, but 
many studies demonstrate the efectiveness. Previous studies have shown efectiveness 
in influenza vaccine, including using laboratory tests to identify the influenza virus (98, 
99, 100, 153, 175). These studies also suggest that influenza vaccination maintaining 
efectiveness requires keeping a high vaccination rate among the total population, 
including the healthy population (herd immunity) (101). Nakano suggested in his paper 
that vaccine eficacy (VE) of influenza should be evaluated in each person but under 
circumstance that a level of herd immunity was kept adequately (102). 
Sugaya suggests that a clear decrease in excess mortality resulted from the school-
located vaccination (SLV) program when seasonal influenza vaccination was 
mandatory for children from 1976 to 1987 and maintaining a high vaccination rate 
among children provided herd immunity and protected vulnerable populations such as 
the elderly (179).  
In this study, the healthier population was less likely to have had flu vaccinations, 
but maintaining an adequate vaccination rate among the healthier population is 
necessary and wil be further addressed in the future. 
Cues to action 
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In this population, among the cue to action factors of the information sources, 
family doctor recommendations became significant after univariate analysis and 
knowing about the vaccination subsidy and communication from local governments 
became significant after univariate and multivariate analysis. The results of this study 
support the results of the previous influenza study by Matsui et al. investigating rural 
communities in Japan and reporting that efective information resources for elderly 
people were medical facilities and town hals (138). 
The factor of family doctor recommendations has almost been established as the 
information source for urging vaccination acceptance (44, 49, 59, 133, 135). When 
participants have a good family doctor, they may have good advice from their doctors. 
Participants commented as folows: 
“I am happy to have a good family doctor. I can folow his recommendations.”  
“I just folow my family doctor because I don’t have enough knowledge about flu 
vaccines.”  
Sometimes family doctor advice is a negative influence when doctors are negative 
concerning vaccinations. Singleton et al. reported in their influenza study of the elderly 
population that when doctors do not recommend influenza vaccinations even if patients 
visit them, their vaccination rate drops (59). In this study population, when participants’ 
doctors have negative opinions about the influenza vaccine, participants tended to 
avoid vaccinations as folows: 
“My doctor says the flu vaccine is inefective (76 years old).”  
“My mother died from brain damage. My physician says the cause might have 
been the flu vaccine (69 years old).”  
These comments may suggest that informing physicians and other multiple resources 
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wil be necessary to raise awareness as wel. Gargano et al. reported that multiple 
sources of information were efective for parents to raise vaccination rate among their 
adolescent children (133). 
A cue to action factor of knowing about the vaccine subsidy became a significant 
positive factor and the barrier factor of the vaccine being expensive became a 
significant negative factor after multivariate analysis. 
In Japan, seasonal influenza vaccination has been included in NIP since 2001 for 
the elderly over 65 years old and for those with high-risk diseases who are over 60 
years old. A few local governments provide the vaccination for free and the elderly 
generaly pay around 1000 to 2500 yen on average depending on the subsidy. Without 
subsidies, it cost around 4000 to 5000 yen, which is expensive. In this study population, 
about 27 percent of the participants, even in the high-risk group, not knowing about the 
subsidy for seasonal influenza vaccination may have hindered the vaccination rate. The 
factor of vaccination being expensive became a barrier. Considering many countries 
provide seasonal influenza vaccinations free of charge to the elderly, a policy change 
from subsidies to being completely free of charge is necessary. 
 
4.4.2.2 Media 
The media plays an important role in public health behavior. The media has been 
utilized for many public health promotions such as in California (Prop 99) for tobacco 
control (188). 
One characteristic of the information source on the flu vaccination of the study 
population was that nearly 45 percent of participants responded that they rely on 
information sources in the media such as newspapers, televisions and the internet. 
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However, after univariate analysis, the factor of learning from the media did not reduce 
non-vaccination risk. The media is sometimes reported as a negative efect as an 
information source (188, 189). In a parent study, Brunson et al. reported that the media 
has sometimes played a negative role for parents for vaccination compliance of their 
children (62). 
During the 2009 H1N1 pandemic, the media overreacted to the pandemic and 
became one source of confusion for rushing people to hospitals to have flu vaccinations. 
There were participants who criticized the media. Participants in this study commented 
as folows: 
“The 2009 H1N1 pandemic turmoil was awful. Everybody rushed to the hospital 
to get vaccinated but many could not get the vaccine. However, the actual victims 
were few. Excessive media reporting may have been responsible for this panic (68 
years old).”  
“The media covers vaccination scarcity too much. This has caused people to be 
insecure (73 years old).” 
As described above, obtaining corect information from the media alone may be 
dificult; several information sources would work for a beter result to raise the 
vaccination rate. 
Barier factors  
In this study, the barier factor of fear of harmful side efects was a significant 
factor for non-vaccination in both adjusted and non-adjusted analysis. According to the 
Center for Disease Control and Prevention (CDC), the seasonal influenza vaccination is 
among the safest medical products. The serious side efect of Guilain-Baré syndrome 
(GBS) is reported one per one milion doses. Many studies show the non-significance 
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of side efects of seasonal influenza vaccine comparing the vaccinated and non-
vaccinated elderly populations (55, 184, 192). However, one percent of the population 
in this paper reported serious side efects of motor or neurological related side efects 
(Table 17). This raises a discrepancy with the above studies concerning safety. Further 
studies to watch over the side efects of seasonal influenza vaccine are necessary. 
Participants commented as folows: 
“I am concerned over side efects. I need corect information about the risks of 
side efects (73 years old).”  
“I wory about side efects. I want open and reliable information about side efects 
such as national databases (74 years old).”  
In order to reduce concerns over side efects, disseminating the merits of 
vaccinations and delivering corect information about the risks of side efects is 
necessary. Establishing open to the public databases such as the Vaccine Adverse 
Event Reporting System (VAERS) in the US or the Database of Adverse Event 
Notifications (DAEN) in Australia that we can freely refer to at anytime about side 
efect information is also necessary. For vaccination, presenting the merits and al 
information including the risks of corect vaccination are crucial. 
One characteristic in this study was vaccine scarcity; participants who responded 
in the author’s study in 2009 especialy commented about the vaccine scarcity learned 
from the lessons in the 2009 H1N1 pandemic as folows: 
“Preparing enough vaccines is the government’s responsibility. They should not 
cut the budget for influenza vaccines (72 years old).”  
“I went to the hospital to get a flu shot this year, but I could not get it due to 
scarcity. Does the Japanese government vaccination policy work wel (72 years 
  
111 
 
old)?”  
Those concerned about influenza vaccine scarcity were significantly more likely to be 
vaccinated. There may be a non-vaccination risk among those not interested in having 
the flu vaccination compared to those concerned about scarcity. 
 
4.4.3 Social factors 
As described in Study I, social factors influence health behaviors including 
vaccination. Low socioeconomic status hinders people from accessing preventive 
services including immunizations (51, 52). 
For influenza, Casey et al. reported that influenza vaccination significantly 
declined in the population 65 years and over living in rural places (53). Armstrong et al. 
suggested that the influenza immunization rate among the elderly 65 years old and over 
is low among the population with low socioeconomic status (54). In a Japanese 
influenza study, Wada reported that low household income is a risk factor for influenza 
vaccination increases among the working age population (171). 
In this study, those who live in rural adjacent areas were less vaccinated than those 
in urban areas after univariate analysis, but not significantly. Those who live in rural 
areas are only 2.4 percent of the total population in this study and corect analysis 
could not be performed. Similarly for the subjective life standard, when we compare 
average and good subjective life standards, those who reported average were less 
vaccinated than those who reported good, but nearly 60 percent of participants reported 
their life standard was good. Thus for socio-economic status no significant results were 
obtained due to population skewing. 
In this study, those with poorer SRH were more vaccinated after univariate 
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analysis. Few studies were found that have investigated SRH and vaccination, but 
Andrew et al. reported in their Canadian study that elderly people who were 65 years 
and older with poorer SRH were more vaccinated against influenza than was 
concordant with this study (194). 
For social activities and participation, Kawachi et al. suggest that social 
participation contribute to one’s health status (176). Kondo et al. report that social 
activities and participation are positively related with health and those with higher 
education and income more actively participate in social activities (157). Supporting 
this, in this study population of university graduates, only 14.5 percent responded that 
they did not participate in any social activities and al the participants progressively 
participated in some activity. However, social activity and participation did not 
influence influenza vaccination increases. This may be because the sample population 
was skewed to a beter subjective life standard and only 4.5 percent were living alone, 
who may benefit from social activities. 
Those with more participation and activities had a slightly higher SRH (r=0.11; 
p=0.007) in this study. Social activity and participation contribute somewhat to the 
population’s health but this needs to be studied further. 
 The non social network factor was studied in this study, but contrary to the 
maternal study, no significant diferences were observed. Many studies have found that 
social networks are mainly a benefit for women or mothers to increase vaccination 
acceptance for their children (62, 63, 64, 186). This is conceivable given that this study 
population consisted of a male population. As mentioned above, family doctor advice 
is a wel-known social network factor to urge vaccination across genders and racial 
diferences. And there are various studies for other preventive behaviors such as cancer 
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screening that suggest social network can benefit for men, too (47, 72, 187). Simpson 
et al. reported in their cholesterol screening study that married men asked more about 
preventive services than unmarried men over 50 years old (65). Cornwel et al. reported 
in their elderly population study that social network characteristics and emotional 
support are associated with hypertension diagnosis and control and that no diferences 
existed between men and women (66). From these studies, it may be early to conclude 
that social networks would not benefit an elderly male population. One participant 
commented: 
“My son is a pharmacist. I can get much information from him and it is very 
helpful.” 
For those living alone and lower socioeconomic populations, social networks have 
potential and may be more efective to raise awareness among the elderly male 
population so that further studies with a variety of socioeconomic statuses wil be 
necessary. 
 
4.5 Conclusion 
In this study, HBM factors could provide potential efective predictors for 
vaccination increases. In addition, healthier populations were less vaccinated and those 
in high-risk groups were not significantly enough vaccinated. 
Considering the first objective of this study to decrease excessive mortality, 
raising awareness is necessary among elderly population. In order to do this, 
disseminating the effectiveness of influenza vaccination, influenza severity, correct 
knowledge about side efects and subsidy information through communication from 
local government, family and atending physicians would be necessary. Nearly 50 
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percent of participants relied on the media to gather information about influenza in this 
study population so the media could be potentialy efective to raise seasonal influenza 
vaccination acceptance among this population. 
 
4.6 Study limitations 
This study was a cross-sectional study with higher education, a comparatively 
higher subjective life standard and living in urban areas. In order to generalize the 
results of this study, further longitudinal study covering a variety of education levels 
and socioeconomic statuses is necessary. 
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Participants
characteristics p value
Age (Ave.±SD) 73.10±5.10 73.21±4.18 0.81 a
 65-74 128 (79.5) 241 (58.6)
 75-93 33 (20.2) 170 (41.4)
Working Status
 Yes 54 (32.3) 158 (38.4) 0.16
 No 113 (67.7) 253 (61.6)
Residential area 
 Urban 111 (76.0) 273 (69.8)
 Rural-adjacent 32 (21.9) 108 (27.6) 0.32 ｂ
 Rural 3 (2.1) 10 (2.6)
Subjective life standards
 Very good 23 (13.9) 77 (18.7)
 Good 71 (43.0) 172 (41.8) 0.48 ｂ
 Average 70 (42.4) 156 (38.0)
 Poor 1 (0.6) 6 (1.5)
Self rated health
　good 128 (81.5) 343 (86.8) 0.08
　poor 29 (18.5) 52 (13.2)
Seasonal influenza vaccination
 Every year/sometimes 109 (65.3) 271 (65.9) 0.89
 Never 58 (34.7) 140 (34.1)
Those who lived with participants 
  None 10 (6.0) 20 (4.9) 0.59
  Living with family 157 (94.0) 391 (95.1)
Sports hours per a week
 Median 4 4
 Maximum 28 26 0.21 ｃ
 Minimum 0 0
a. p value and 95%CI were obtained by student t test comparing two samples.
b. p values were obtained by Fisher extract test.
p values were otained by X2 test for other valuables.
Total % is not necessarily 100% due to missing values.
2009　（n=167) 2010 (n=411)
Table 10 Goodness of fit test to test the diferences of characteristics between two 
groups (N=578)  
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Seasonal influenza vaccination status
Participants characteristics Sometimes Unadjusted OR p 
           n (%)           Never /Every year  (95%CI) value
Age (Ave.±SD) 73.19±4.43 72.0±4.04 73.80±4.47  (1.06 - 2.55) <0.01 ** a
 65-74 369 (64.5) 145 (39.3) 224 (60.7) 1
 75-93 203 (35.5) 52 (25.6) 151 (74.4) 0.53 (0.36-0.78) <0.01 ** †
Working Status
 Yes 212 (36.7) 78 (36.8) 134 (63.2) 1.19 (0.84-1.70) 0.33 †
 No 366 (63.3) 120 (32.8) 246 (67.2) 1
Residential area 
 Urban 384 (71.5) 127 (33.1) 257 (66.9) 1
 Rural-adjacent 140 (26.1) 56 (40.0) 84 (60.0) 1.35 (0.91-2.01) 0.14 †
 Rural 13 (2.4) 3 (23.1) 10 (76.9) 0.61 (0.16-2.25) 0.45 †
 Prefecture: Tokyo (252, 43%), Kanagawa (72, 12.3%), Saitama (34, 5.8%), Chiba (58, 9.9%)
         Others (162, 29.0%)
Self rated health
　good 471 (85.3) 169 (35.9) 302 (64.1) 1
　poor 81 (14.7) 18 (22.2) 63 (77.8) 0.51 (0.29-0.89) 0.02 * †
Subjective life standard
　very good 100 (17.3) 28 (28.0) 72 (72.0) 1
 good 243 (42.1) 83 (34.2) 160 (65.8) 1.33 (0.80-2.22) 0.27 †
 average 226 (39.2) 84 (37.2) 142 (62.8) 1.52 (0.91-2.54) 0.11 †
 poor 7 (1.2) 2 (1.0) 5 (1.3) 1.03 (0.29-5.61) 0.97 †
Sex
 Male    568 (98.4) 196 (34.5) 372 (65.4)
 Female 5 (0.9) 1 (0.5) 4 (1.1)
 Unknown 4 (0.7) 1 (0.5) 3 (0.8)
Seasonal influenza vaccination
Every year 272 (47.1)
Sometimes 108 (18.7)  
Never 198 (34.2)
Those who lived with participants 
  None 26 (4.5) 6 (23.1) 20 (76.9) 1
  Spouse 359 (62.1) 121 (33.7) 238 (66.3) 1.70 (0.66-4.33) 0.27 †
  Spouse and children 141 (24.4) 53 (37.6) 88 (62.4) 2.00 (0.76-5.32) 0.16 †
  Spouse, children, grandchildren19 (3.3) 7 (36.8) 12 (63.2) 1.94 (0.53-7.17) 0.32 †
  Others 26 (4.5) 7 (26.9) 19 (73.1) 1.23 (0.35-4.32) 0.75 †
　　Temporary living alone 7 (1.2) 4 (2.0) 3 (0.8) 4.44 (0.77-25.65) 0.10 †
Flu-like symptoms within recent two years
179 (32.2) 45 (25.1) 134 (74.9) 0.54 (0.36-0.80) 0.002 ** †
377 (67.8) 145 (38.5) 232 (61.5) 1
†Unadjusted ORs were obtained from univariate logistic regression analysis of dependent variable
as non vaccination of seasonal influenza.
a. p value and 95%CI were obtained by student t test for participants' age.
ｂ.p value was obtained by Mann-Whitney U test.
** denote significance of p value is less than 0.01.* denote significance of p value is less than 0.05.
Total % is not necessarily 100 % due to missing values.
Table 11 Demographic characteristics of participants and seasonal influenza vaccination 
status (N=578) 
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Table 12 Participants’
Current and past
medical histories Sometimes Unadjusted OR p 
 (n=878) n (%) Never /Every year  (95%CI) value
Stroke 14 (2.4) 5 (35.7) 9 (64.3) 1.06 (0.35-3.22) 0.91 †
564 (97.6) 193 (34.2) 371 (65.8) 1
Hypertension 166 (28.7) 50 (30.1) 116 (69.9) 0.77 (0.52-1.13) 0.18 †
412 (71.3) 148 (35.9) 264 (64.1) 1
Cardiovascular disease 55 (9.5) 13 (23.6) 42 (76.4) 0.57 (0.23-1.08) 0.08 †
   523 (90.5) 185 (35.4) 338 (64.6) 1
Liver disease 34 (5.9) 14 (41.2) 20 (58.8) 1.37 (0.67-2.77) 0.39 †
　　 544 (94.1) 184 (33.8) 360 (66.2) 1
Galbladder disease  30 (5.2) 12 (40.0) 18 (60.0) 1.30 (0.61-2.75) 0.50 †
　　　 548 (94.8) 186 (33.9) 362 (66.1) 1
Diabetes 63 (10.9) 19 (30.2) 44 (69.8) 0.81 (0.46-1.43) 0.46 †
515 (89.1) 179 (34.8) 336 (65.2) 1
Gastroduodenal disease 58 (10.0) 18 (31.0) 40 (69.0) 0.85 (0.47-1.53) 0.59 †
　　　 520(90.0) 180 (34.6) 340 (65.4) 1
Tuberculosis 34 (5.9) 12 (35.3) 22 (64.7) 1.05 (0.51-2.16) 0.90 †
544 (94.1) 186 (34.3) 358 (65.8) 1
Asthma 24 (4.2) 5 (20.8) 19 (79.2) 0.67 (0.24-1.90) 0.46 †
  /Chronic bronchitis 554 (95.8) 193 (34.8) 361 (65.2) 1
Anemia 10 (1.7) 4 (40.0) 6 (60.0) 1.29 (0.36-4.61) 0.70 †
568 (98.3) 194 (34.2) 374 (65.8) 1
Rheumatism /gout 11 (1.9) 8 (72.7) 3 (27.3) 5.28 (1.38-2.10) 0.015 *†
   /Arthritis 567 (98.1) 190 (33.5) 377 (66.5) 1
Cancer 74 (12.8) 27 (36.5) 47 (63.5) 1.12 (0.67-1.86) 0.67 †
504 (87.2) 171 (33.9) 333 (66.1) 1
Appendicitis 71 (12.3) 18 (24.5) 53 (74.6) 0.62 (0.35-1.09) 0.09 †
507 (87.7) 180 (35.5) 327 (64.5) 1
Bone fracture 42 (7.3) 15 (35.7) 27 (64.3) 1.07 (0.56-2.01) 0.84 †
536 (92.7) 183 (34.1) 353 (65.9) 1
Pneumonia 28 (4.8) 9 (32.1) 19 (67.9) 0.90 (0.40-2.03) 0.80 †
549 (95.1) 189 (34.4) 361 (65.6) 1
Hay fever 91 (15.7) 28 (30.8) 63 (69.2) 0.83 (0.51-1.34) 0.45 †
487 (84.3) 170 (34.9) 317 (65.1) 1
Other alergies 18 (3.1) 7 (38.9) 11 (61.1) 1.23 (0.47-3.22) 0.67 †
560 (96.9) 191 (34.1) 369 (65.9) 1
Others (52)
 Low back pain（9), Prostatomegaly（8), Glaucoma (3), Colon polyp (4), Ureteral calculi (2), 
 Rupture of Achiles tendon (1), prostatitis (1), Asperger's syndrome(1), Meniere disease(1), 
 Hypercholesterolemia (1), Colon diverticulitis (1), Sinusitis (1), Retinal hemorrhages (1), 
 Abnormal lipido metabolism (1), Empyema (1), Parkinson's disease (1), Sleep apenea syndrome (1), 
 Fundus hemorrhage (1), Chronic gastroenteritis (1), Thrombocythemia (1), Pancreatitis (1), 
Number of histories
　0-2 405 (70.1) 146 (36.0) 259 (64.0)
　3-5 163 (28.2) 51 (31.3) 112 (68.7) 0.015*a
　6-9 10 (1.7) 1 (10) 9 (90)
a. .p value was obtained by Mann-Whitney U test.
† Unadjusted ORs were obtained from univariate logistic regression analysis of dependent variable
as non vaccination of seasonal influenza.
** denote significance of p value is less than 0.01.* denote significance of p value is less than 0.05.
Seasonal influenza
 vaccination status
 current and past medical histories (multiple choice) (N=578) 
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Table 13 Healthy lifestyle and influenza vaccination status (multiple choice) (N=578) 
Do you practice any healthy habits to keep your health? 
 
 
 
 
 
Total Sometimes Unadjusted OR p 
Healthy habits     n (%)           Never /Every year  (95%CI) value
Exercise or walking regularly 433 (74.9) 154 (35.6) 279 (64.4)1.27 (0.85-1.90) 0.25 †
145 (25.1) 44 (30.3) 101 (69.7) 1
　　Sports hours/week　 0.045* a
　　　　0 hour 150 (26.7) 47 (31.3) 103 (68.7)
　　　　1-5 hours 234 (41.6) 71 (37.2) 163 (43.9)
　　　　6-10 hours 134 (23.8) 50 (37.3) 84 (62.7)
　　　　11-15 hours 32 (5.7） 16 (50) 16 (50)
　　　　16-28 hours 12 (2.1) 7 (3.7) 5 (1.3)
Measuring weight regularly 293 (50.7) 93 (31.7) 200 (68.3)0.80 (0.57-1.13) 0.2 †
285 (49.3) 105 (36.8) 180 (63.2) 1
Measuring blood pressure regularly 255 (44.2) 73 (28.6) 182 (71.4)0.64 (0.45-0.91) 0.013* †
322 (55.8) 124 (38.5) 198 (61.5) 1
Quit smoking or decrease number of a cigarrettes per a day
192 (33.2) 72 (37.5) 120 (62.5)1.24 (0.86-1.78) 0.25 †
 386 (66.8) 126 (32.6) 260 (67.4) 1
Taking rest regularly 177 (30.7) 54 (30.5) 123 (69.5)0.79 (0.54-1.15) 0.22 †
400 (69.3) 143 (35.8) 257 (64.3) 1
Quit alchol drinking or decrease drinking volume
121 (21.0) 29 (24.0) 92 (76.0)0.54 (0.34-0.85) 0.009** †
 456 (79.0) 168 (36.8) 288 (63.2) 1
Relieving stress 101 (17.5) 27 (26.7) 74 (73.3)0.66 (0.41-1.06) 0.09
476 (82.5) 170 (35.7) 306 (64.3) 1 †
†Unadjusted ORs were obtained from univariate logistic regression analysis 
a. .p value was obtained by Mann-Whitney U test.
Note：Totals are not necessarily match because of missing values.
** denote significance of p value is less than 0.01.* denote significance of p value is less than 0.05.
Seasonal influenza
 vaccination status
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Table 14 Preventive practices besides vaccination and seasonal influenza vaccination status 
(multiple choice) （N=578) 
 
 
Total Sometimes Unadjusted OR p 
Practices           n (%)           Never /Every year  (95%CI) value
Taking good nutrition 338 (58.5) 111 (32.8) 227 (67.2) 0.86 (0.61-1.22) 0.39 † 
240 (41.5) 87 (36.3) 153 (63.7) 1
Having enough sleep 328 (56.8) 112 (34.1) 216 (65.9) 1.00 (0.71-1.42) 0.998 † 
249 (43.2) 85 (34.1) 164 (65.9) 1
Washing hands 391 (67.8) 117 (29.9) 274 (70.1) 0.57 (0.39-0.81) <0.01** † 
186 (32.2) 80 (43.0) 106 (57.0) 1
Gargling 405 (70.1) 119 (29.4) 286 (70.6) 0.50 (0.43-0.72) <0.01** † 
173 (29.9) 79 (39.9) 94 (24.7) 1
Wearing masks 148 (25.6) 38 (19.2) 110 (74.3) 0.58 (0.38-0.89) 0.01* † 
 in public places 430 (74.4) 160 (80.8) 270 (71.1) 1
Avoid crowded places 146 (25.3) 46 (31.5) 100 (68.5) 0.85 (0.56-1.27) 0.42 † 
432 (74.7) 152 (35.2) 280 (64.8) 1
Humidify rooms 92 (15.9) 27 (13.6) 65 (17.1) 0.77 (0.47-1.24) 0.28 † 
486 (84.1) 171 (35.2) 315 (64.8) 1
† Unadjusted ORs were obtained from univariate logistic regression analysis of dependent variable
as non vaccination of seasonal influenza.
Total values are not necessarily match by calculation due to missing values.
** denote significance of p value is less than 0.01.* denote significance of p value is less than 0.05.
Seasonal influenza
 vaccination status
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Table 15 Knowledge about symptoms when contracted to flu or cold (multiple choice) 
(N=578) 
 
 
 
 
 
 
 
 
 
 
Expected symptoms Flu Cold
High fever 535 (92.6) 182 (31.5)
Low-grade fever 48 (8.3) 384 (66.6)
Joint or muscle pain 377 (65.2) 168 (29.1)
Feel exhausted 380 (65.9) 425 (73.5)
Sore throat 129 (22.4) 233 (40.3)
Sneeze 259 (44.8) 461 (79.9)
Total 1728 1853
Total % is not 100% due to multiple choice question.
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Table 16 Reasons for non-vaccination of seasonal influenza vaccine (Multiple choice) 
（N=578、n=198) 
 
 
 
 
 
 
ｎ ％
The vaccine is unnecessary 57 28.8
The vaccine is not efective 31 15.7
The vaccine is bothersome 24 12.1
Fear of harmful side efects 20 10.1
The shot is expensive 5 2.5
Being busy 4 2.0
Others; 11 5.6
I am healthy（3), I took pneumococcus vaccine（１）, Government 
administration failure（１）, I distrust vaccination (1), Other preventive
measures are important (1), I wil contract flu if I take vaccine（１）,
I hate hospital （１）, I try not to contract flu（1）, I have no knowledge 
about vaccine（１）
Total 162
Total % is not 100% due to multiple choice question.
   Reason for non-vaccination
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Table 17 Reported side efects experiences among participants who had seasonal 
influenza vaccinations (n=379) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reported side efects n (%)
Sweling/Pain at injection site 14 (3.7)
Fever/Chiling 13 (8.3)
Movement disorder/Disturbance in consciousness 4 (1.1)
Alergic reactions 2 (0.4)
Other (unknown) 1 (0.3)
None 335 (91.1)
Note: Total values are not necessarily match due to missing values.
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Table 18 Health Belief Model factors and seasonal influenza vaccination status (N=578) 
 
 
Seasonal influenza vaccination status
Sometimes Unadjusted p 
   n (%)           Never /Every year OR (95%CI) value
Perceived vulnerability to flu or cold
Do you think you are vulnerable to flu or cold?
Yes 114 (20.1) 17 (14.9) 97 (85.1) 0.27 (0.16-0.48) <0.001 ** †
No 454 (79.9) 117 (39.0) 277 (61.0) 1
Perceived eficacy of seasonal infuenza vaccine 
Do you think influenza vaccine is efective?
Yes   406 (70.2) 56 (28.3) 350 (92.1) 1
No 172 (29.8) 142 (82.6) 30 (17.4) 30.04 (18.48-48.82) <0.01 ** †
Perceived severity of influenza
Do you have a correct knowledge of symptoms and diferences between flu from cold?
Yes 484 (84.3) 156 (32.2) 328 (67.8) 0.54 (0.35-0.86) <0.01 ** †
No 90 (15.7) 42 (46.7) 48 (53.3) 1
Cue to the action
Recommendation from family doctor
Yes 55 (9.5) 8 (14.5) 47 (85.5) 0.30 (0.14-0.65) 0.002 ** †
No 523 (90.5) 190 (36.3) 333 (63.7) 1
Knowing subsidy to the vaccine
Yes 415 (73.1) 101 (24.3) 314 (75.7) 0.21 (0.14-0.31) <0.001 ** †
No 153 (26.9) 93 (60.8) 60 (39.2) 1
Friends’or family’s recommendations
Yes 15 (2.6) 5 (33.3) 10 (66.7) 0.96 (0.32-2.84) 0.94 †
No 563 (97.4) 193 (34.3) 370 (65.7) 1
Communication from local governments
Yes 30 (5.2) 4 (13.3) 26 (86.7) 0.28 (0.10-0.82) 0.016 * †
No 548 (94.8) 194 (35.4) 354 (64.6) 1
Academic journals or experts’information
Yes 26 (4.5) 8 (30.8) 18 (69.2) 0.85 (0.36-1.98) 0.70 †
No 552 (95.5) 190 (34.4) 362 (65.6) 1
Learning from booklets or brochures obtained at 
   hospitals or public places
Yes 9 (1.6) 1 (11.1) 8 (88.9) 0.24 (0.03-1.90) 0.18 †
No 569 (98.4) 197 (34.6) 372 (65.4) 1
Learning from the media (TV, internet, magazines)
Yes 257 (44.5) 90 (35.0) 167 (65.0) 1.06 (0.75-1.50) 0.73 †
No 321 (55.5) 108 (33.6) 213 (66.4) 1
Only through non social network information sources  
Yes 283 (49.0) 96 (33.9) 187 (66.1) 0.97 (0.69-1.37) 0.87 †
No 295 (51.0) 102 (34.6) 193 (65.4) 1
Cont'd to next page
HBM factors
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Cont’d from previous page        
 
Seasonal influenza vaccination
Sometimes Unadjusted OR p 
  n (%)           Never /Every year  (95%CI) value
Perceived barriers
Fear of harmful side efects
Yes 68 (11.8) 48 (70.6) 20 (29.4) 6.67 (3.71-12.00) <0.001 ** †
No 510 (88.2) 150 (29.4) 362 (70.6) 1
Information is scarce
Yes 42 (7.3) 16 (38.1) 26 (61.9) 1.20 (0.63-2.29) 0.59 †
No 536 (92.7) 182 (34.0) 354 (66.0) 1
The vaccination is expensive
Yes 33 (5.7) 16 (48.5) 17 (51.5) 1.88 (0.93-3.81) 0.08 †
No 545 (94.3) 182 (33.4) 363 (66.6） 1
Concern over vaccine scarcity
Yes 32 (5.5) 4 (12.5) 28 (87.5) 0.26 (0.90-0.75) 0.013 * †
No 546 (94.5) 194 (35.5) 352 (64.5) 1
Being busy
Yes 9 (1.6) 8 (88.9) 1 (11.1) 0.001 ** a
No 569 (98.4) 190 (33.4) 379 (66.6)
The vaccination is Unnecessary
Yes 114 (19.7) 108 (94.7) 6 (5.3)75.4 (32.12-177.20)<0.001 ** †
No 464 (80.3) 90 (19.4) 374 (80.6) 1
WTP (Yen)
1000 157 (33.4) 54 (42.9) 103 (65.6)
5000 292 (62.1) 70 (24.0) 222 (64.5)
10000 17 (3.6) 1 (5.9) 16 (94.1) <0.001 ** ｂ
20000 1 (0.2) 0 (0.0) 1 (0.3)
  >20000  3 (0.6) 1 (33.3) 2 (66.7)
†Unadjusted ORs were obtained from univariate logistic regression analysis of dependent 
variable as non vaccination of flu.
a. p value was obtained by Fisher Exact Test due to assumption for χ2 test was unmet.
ｂ.p value was obtained by Mann-Whitney U test.
** denote significance of p value is less than 0.01.
*  denote significance of p value is less than 0.05.
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Table 19 Barier keywords extracted from open-ended question about free opinion 
about influenza vaccination by Text Analysis (N=578, n=324) 
 
 
 
Categories ｎ ％
Vaccine Policy (problem, bad, etc.) 59 10.1
Eficacy (not efective, doubtful, etc.) 52 8.9
Information （scarce, scarcity, etc.） 43 7.3
Vaccine Scarcity (scarce, not enough, etc.)33 5.6
Expensive, Subsidy (need, etc.) 32 5.5
Accessibility (late, problem, etc.) 30 5.1
Pandemic, Outbreak (worry, scary, etc.) 27 4.6
Side efect, Safety (worry, scary, etc.) 26 4.4
Media (mess, panic, etc.) 24 4.1
Priority (problem, bad, etc.) 13 2.2
Cost efective (wonder, doubt, etc) 7 1.2
Facility, Hospital (far, worry, etc.) 6 1
Total 352
        IBM Text Analytics for Surveys 4 (English ver.)
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Table 20   Groups and organizations respondents participated in (Multiple choice) 
（N=578) 
 
 
 
 
 
 
 
 
 
 
 
 
Organization/Group ｎ (%)
Elderly clubs 42 (7.3)
Neighborhood associations127 (22.0)
Women's associations 1 (0.2)
Hobby clubs 208 (36.0)
Fitness or sports related clubs154 (26.7)
Study or culture clubs 120 (20.8)
Civic activity clubs 13 (2.2)
Religious organizations 25 (4.3)
Volunteer organizations 90 (15.6)
Commerce and industry associations41 (7.1)
Retiree organizations 172 (29.8)
Employment center service for elderly people17(2.9)
None 132 (22.9)
Total 1010
Total % is not 100% due to multiple choice question.
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Table 21 Social activities respondents participated in (N=578) 
 
 
 
 
 
 
 
 
 
 
 
Activities ｎ (%)
Fitness and sports 207 (35.9)
Hobbies (culture) 158 (27.4)
Academic activities (research or art) 110 (19.1)
Community activities 54 (9.4)
Productive work (gardening or dispatched work) 34 (5.9)
Neigborhood security activities 12 (2.1)
Home care support for the elderly 12　（2.1)
Life and environment activities 10 (30.3)
Support activities for the elderly (driving etc) 6 (1.0)
Support activities for schools or children 8 (1.4)
None 84 (14.5)
Total 695
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Table 22 Multivariate analysis variable selection by step-down method using step-wise 
likelihood analysis 
 (IBM SPSS 23) Cont’
Lower Upper
Flulike history 2 years .993 .806 1.516 1 .218 2.699 .556 13.107
Perceived vulnerability to
flu -2.297 .590 15.137 1 .000 .101 .032 .320
Perceived severity -.476 .437 1.188 1 .276 .621 .264 1.462
Perceived efficacy 3.650 .386 89.531 1 .000 38.480 18.066 81.960
Barrier expensive 2.067 .674 9.393 1 .002 7.898 2.106 29.611
Willing To Pay .023 .269 .007 1 .931 1.024 .604 1.736
Age -.095 .039 5.991 1 .014 .909 .843 .981
Number of medical histories -.035 .143 .059 1 .808 .966 .730 1.277
Self Rated Health -.341 .550 .384 1 .535 .711 .242 2.090
Rheumatism/gout/arthritis 1.728 1.242 1.934 1 .164 5.627 .493 64.216
Cardiovascular disease -1.313 .739 3.154 1 .076 .269 .063 1.146
Sports hours per a week .033 .038 .779 1 .377 1.034 .960 1.113
Barrier side effect 1.681 .515 10.666 1 .001 5.373 1.959 14.737
Family doctor's -1.203 .630 3.652 1 .056 .300 .087 1.031
  recommendation
Communication from local -1.649 .954 2.985 1 .084 .192 .030 1.248
  govt
Knowing subsidy -1.538 .372 17.071 1 .000 .215 .104 .446
Constant 6.298 2.940 4.589 1 .032 543.454
Flulike history 2 years .996 .805 1.532 1 .216 2.708 .559 13.117
Perceived vulnerability to
flu -2.295 .590 15.138 1 .000 .101 .032 .320
Perceived severity -.478 .436 1.202 1 .273 .620 .264 1.457
Perceived efficacy 3.647 .383 90.446 1 .000 38.344 18.085 81.298
Barrier expensive 2.058 .667 9.510 1 .002 7.832 2.117 28.975
Age -.095 .039 6.043 1 .014 .909 .843 .981
Number of medical histories -.035 .143 .059 1 .808 .966 .730 1.278
Self Rated Health -.338 .549 .379 1 .538 .713 .243 2.091
rheumatism/gout/arthritis 1.722 1.240 1.927 1 .165 5.595 .492 63.629
Cardiovascular disease -1.310 .739 3.144 1 .076 .270 .063 1.148
Sports hours per a week .033 .037 .771 1 .380 1.033 .960 1.112
Barrier side effect 1.681 .514 10.678 1 .001 5.370 1.960 14.717
Family doctor's -1.202 .630 3.647 1 .056 .300 .087 1.032
  recommendation
Communication from local -1.626 .914 3.161 1 .075 .197 .033 1.181
  govt
Knowing subsidy -1.537 .372 17.061 1 .000 .215 .104 .446
Constant 6.355 2.865 4.922 1 .027 575.532
Step Flulike history 2 years 1.006 .805 1.563 1 .211 2.735 .565 13.236
3a Perceived vulnerability toflu -2.317 .584 15.755 1 .000 .099 .031 .310
(cont'Perceived severity -.486 .435 1.246 1 .264 .615 .262 1.444
d) Perceived efficacy 3.643 .383 90.388 1 .000 38.190 18.023 80.924
Barrier expensive 2.043 .664 9.476 1 .002 7.717 2.101 28.346
Step
1a
Step
2a
B SD
p
value Exp(B)
EXP(B)  95% CI
Wald df
Variables in the equations
d to next page 
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         Cont’d from previous page 
                                    Cont’d to next page
Lower Upper
Step Age -.095 .039 6.053 1 .014 .909 .843 .981
3a Self Rated Health -.361 .541 .446 1 .504 .697 .242 2.011
(cont'Rheumatism/gout/arthritis 1.725 1.242 1.930 1 .165 5.614 .492 64.020
d) Cardiovascular disease -1.346 .723 3.469 1 .063 .260 .063 1.073
Sports hours per a week .033 .037 .767 1 .381 1.033 .960 1.112
Barrier side effect 1.682 .514 10.706 1 .001 5.379 1.963 14.735
Family doctor's -1.221 .623 3.839 1 .050 .295 .087 1.000
  recommendation
Communication from local -1.634 .914 3.199 1 .074 .195 .033 1.170
  govt
Knowing subsidy -1.540 .372 17.158 1 .000 .214 .103 .444
Constant 6.301 2.849 4.891 1 .027 545.259
Flulike history 2 years .989 .810 1.492 1 .222 2.689 .550 13.144
Perceived vulnerability to
flu -2.328 .581 16.046 1 .000 .098 .031 .305
Perceived severity -.461 .434 1.127 1 .288 .631 .270 1.477
Perceived efficacy 3.653 .383 90.741 1 .000 38.596 18.202 81.842
Barrier expensive 2.028 .657 9.528 1 .002 7.598 2.097 27.534
Age -.098 .038 6.473 1 .011 .907 .841 .978
Rheumatism/gout/arthritis 1.756 1.249 1.977 1 .160 5.789 .501 66.955
Cardiovascular disease -1.430 .702 4.145 1 .042 .239 .060 .948
Sports hours per a week .034 .037 .859 1 .354 1.035 .962 1.113
Barrier side effect 1.664 .510 10.653 1 .001 5.281 1.944 14.343
Family doctor's -1.249 .628 3.953 1 .047 .287 .084 .982
  recommendation
Communication from local -1.622 .914 3.150 1 .076 .197 .033 1.184
  govt
Knowing subsidy -1.547 .371 17.365 1 .000 .213 .103 .441
Constant 6.449 2.845 5.138 1 .023 631.816
Flulike history 2 years .939 .807 1.353 1 .245 2.556 .526 12.428
Perceived vulnerability to
flu -2.316 .578 16.079 1 .000 .099 .032 .306
Perceived severity -.457 .433 1.114 1 .291 .633 .271 1.479
Perceived efficacy 3.667 .384 91.392 1 .000 39.117 18.446 82.951
Barrier expensive 2.052 .649 9.992 1 .002 7.782 2.181 27.771
Age -.101 .038 6.968 1 .008 .904 .839 .974
Rheumatism/gout/arthritis 1.679 1.265 1.762 1 .184 5.361 .449 63.984
Cardiovascular disease -1.477 .700 4.452 1 .035 .228 .058 .900
Barrier side effect 1.623 .508 10.218 1 .001 5.070 1.874 13.719
Family doctor's -1.170 .620 3.569 1 .059 .310 .092 1.045
  recommendation
Communication from local -1.514 .902 2.818 1 .093 .220 .038 1.289
  govt
Knowing subsidy -1.533 .371 17.081 1 .000 .216 .104 .447
Constant 6.815 2.810 5.881 1 .015 911.733
B
Step
4a
Step
5a
SD Wald df
p
value Exp(B)
EXP(B)  95% CI
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              Cont’
Lower Upper
Flulike history 2 years 1.024 .791 1.679 1 .195 2.785 .591 13.118
Perceived vulnerability to
flu -2.252 .568 15.715 1 .000 .105 .035 .320
Perceived efficacy 3.707 .383 93.900 1 .000 40.744 19.249 86.241
Barrier expensive 2.057 .651 9.971 1 .002 7.824 2.182 28.051
Age -.099 .038 6.929 1 .008 .905 .841 .975
Rheumatism/gout/arthritis 1.621 1.260 1.654 1 .198 5.057 .428 59.767
Cardiovascular disease -1.549 .703 4.855 1 .028 .213 .054 .843
Barrier side effect 1.627 .509 10.238 1 .001 5.091 1.879 13.795
Family doctor's -1.165 .617 3.566 1 .059 .312 .093 1.045
  recommendation
Communication from local -1.581 .907 3.037 1 .081 .206 .035 1.218
  govt
Knowing subsidy -1.532 .371 17.091 1 .000 .216 .104 .447
Constant 6.304 2.737 5.305 1 .021 546.735
Perceived vulnerability to
flu -2.087 .541 14.880 1 .000 .124 .043 .358
Perceived efficacy 3.684 .380 93.973 1 .000 39.821 18.906 83.874
Barrier expensive 2.019 .650 9.648 1 .002 7.533 2.107 26.937
Age -.104 .037 7.686 1 .006 .902 .838 .970
Rheumatism/gout/arthritis 1.577 1.255 1.579 1 .209 4.843 .413 56.719
Cardiovascular disease -1.560 .700 4.962 1 .026 .210 .053 .829
Barrier side effect 1.563 .504 9.629 1 .002 4.774 1.779 12.813
Family doctor's -1.044 .607 2.957 1 .086 .352 .107 1.157
  recommendation
Communication from local -1.579 .912 2.995 1 .084 .206 .035 1.233
  govt
Knowing subsidy -1.524 .369 17.029 1 .000 .218 .106 .449
Constant 6.641 2.708 6.014 1 .014 765.499
Perceived vulnerability to
flu -2.081 .534 15.170 1 .000 .125 .044 .356
Perceived efficacy 3.679 .378 94.906 1 .000 39.606 18.894 83.026
Barrier expensive 1.990 .648 9.425 1 .002 7.319 2.054 26.082
Age -.105 .037 7.885 1 .005 .900 .837 .969
Cardiovascular disease -1.588 .700 5.143 1 .023 .204 .052 .806
Barrier side effect 1.643 .500 10.787 1 .001 5.172 1.940 13.787
Family doctor's -1.019 .602 2.860 1 .091 .361 .111 1.176
  recommendation
Communication from local -1.603 .912 3.094 1 .079 .201 .034 1.201
  govt
Knowing subsidy -1.512 .366 17.103 1 .000 .221 .108 .451
Constant 6.751 2.707 6.217 1 .013 854.833
a. Step 1: Candidate variables; Flulike history 2 years, Perceived vulnerability to flu,
Perceived severity, Perceived efficacy, Barrier expensive, Willing To Pay, Age, Number of
medical histories, SRH, Rheumatism/gout/arthritis, Cardiovascular disease, Sports hours per a
week, Barrier side effect, Family doctor's recommendation, Communication from local govt,
Knowing subsidy.
Wald df
p
value Exp(B)
EXP(B)  95% CI
Step
8a
Step
6a
Step
7a
B SD
d from previous page 
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Table 23 Multivariate analysis findings for predicting non immunization of seasonal 
influenza vaccine (N=578) 
 
 
 
 
 
Adjusted OR (95%CI)p value
 Age 0.90 (0.84-0.96) 0.01*
 History of cardiovascular diseases 0.26 (0.09-0.78) 0.016*
 History of rheumatism/gout/arthritis 10.90 (1.51-78.77) 0.018*
 Perceived vulnerability to flu or cold 0.13 (0.05-0.31) <0.001**
 Perceived eficacy of seasonal infuenza vaccine
   The vaccine is not efective  35.10 (19.56-66.37) <0.001**
 Cue to the action
 Recommendations from family doctors 0.39 (0.13-1.19) 0.09
 Knowing subsidy to the vaccine 0.21 (0.11-0.39) <0.001**
 Communication from local government 0.12 (0.02- 0.76) 0.024*
 Perceived barriers
  The vaccine is expensive 7.89 (2.41-25.80) 0.001**
  Fear of harmful side efects 8.74 (3.62-21.11) <0.001**
** denote p value is less than 0.01
*  denote p value is less than 0.05
Adjusted ORs were obtained from multivariate analysis of dependent variable 
as non vaccination of flu. 
Hosmer Lemshaw test, ROC analysis, R2=0.32
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Table 24 Main extracted keywords of open-ended question about “concerns” (N=300) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Morphological analysis、keyword associator (Fujitsu Trend Search 2008)  
n
76
64
59
40
Governmenｔ 40
28
Co-payment 28
Health Care Program 28
 for the Elderly Aged 75 Years and Over
23
21
Flu 21
20
19
Local Health Care 19
18
Burden 18
Excessive 18
16
15
13
Primary Care Doctor 13
Quality 13
12
Medical Expense 12
11
Others 55
Total 994
Categories
Health Care
Hospitals
Doctor
Policy
Scarcities
Increase
Access
Expensive
Vaccine
Support
Prevention
Diseases
System
Infectious Diseases
Society, Health System
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Figure 14 Influenza vaccination rates among elderly population 65 years and older by OECD 
countries (Countries data not available are not included in this graph. Author created the 
graph based on Health care use, OECD Data 2015, 
htps:/data.oecd.org/healthcare/influenza-vaccination-rates.htm (Accessed March 01, 2016) 
% 
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Figure 15 Univariate analysis result of seasonal influenza study: Flu-like symptoms 
within recent 2 years (N=578) 
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Figure 16 Univariate analysis result of seasonal influenza study: Self Rated Health and 
seasonal influenza vaccination (N=578) 
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Figure 17 Univariate analysis result of seasonal influenza study: Perceived vulnerability 
to flu or cold (N=578) 
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Figure 18 Univariate analysis result of seasonal influenza study: Perceived severity of 
flu (N=578) 
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Figure 19 Univariate analysis result of seasonal influenza study: Cue to the action; 
recommendation from family doctors (N=578) 
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Figure 20 Univariate analysis result of seasonal influenza study: Cue to the action; 
knowing the subsidy to the vaccine (N=578) 
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Figure 21 Univariate analysis result of seasonal influenza study: Cue to the action; 
communication from local government (N=578) 
  
  
145 
 
 
 
 
 
 
 
 
Figure 22 Univariate analysis result of seasonal influenza study: Perceived eficacy of 
seasonal influenza vaccine (N=578) 
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Figure 23 Univariate analysis result of seasonal influenza study: Perceived barriers: fear 
from harmful side efects (N=578) 
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Figure 24 Univariate analysis result of seasonal influenza study: Perceived bariers: 
being busy (N=578) 
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Figure 25 Univariate analysis result of seasonal influenza study: Perceived bariers: 
unnecessary (N=578) 
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Figure 26 Univariate analysis result: Concerning over vaccine scarcity (N=578) 
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Figure 27 Concept mapping of main extracted keywords of open-ended question about 
“concerns” (N=300) 
(Fujitsu Trend Search 2008 Concept Mapping: After default layout process, author 
realigns the keywords) 
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Chapter V 
 
General Discussion 
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In the studies in this dissertation, the author focuses on two important and 
prioritized immunization related public health issues and explores factors based on 
methodologies and the Health Belief Model that have not been suficiently examined in 
Japanese studies. The author is able to demonstrate expectable solutions for 
potentialities for both the studies in this dissertation. The implications and insights 
obtained through Studies I and I are described in the section below. 
 
5.1 Methodology 
One objective of the studies in this paper was to beter evaluate the colected data 
for beter results in limited situations. Even though many questionnaires were sent to 
potential participants, the number of questionnaires recovered was smaler than 
expected with 226 in Study I and 586 in Study I. 
Given this limited situation and to maximize data evaluation, the triangulation 
method was adopted in both Studies I and I. The method uses qualitative and 
quantitative methods together by concurrently colecting data and integrating them into 
one study. This enabled more deliberate consideration, focusing on participant opinions, 
even if they were smal in number and using the quantitative method alone would have 
neglected them. For example, in Study I, a few mothers among the university-
graduated mothers believed that contracting mumps was beter for acquiring immunity 
than having vaccinations. 
The quantitative analysis in this paper also used a selection method to find 
variables for multivariate analysis. Conventional automated selection methods were 
not used and variables were widely selected by increasing the threshold values of 
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selections. In this selection, both significant variables after univariate analysis and 
variables close to significant levels were considered as candidates, contrary to 
conventional selection methods. But in Study I, due to limited sample size (N= 224) 
and to avoid over-fiting the multivariate model, this method could not be applicable. 
In Study I, in this selection process though, two variables noticeably showed 
significance after multivariate analysis, even though they were not significant after 
univariate analysis. The results are summarized in Summary Table 1; the two variables 
are enclosed in a square in the table. We tend to pay atention to variables that have 
shown statistical significance in univariate analysis, not to non-significant variables. 
Among these variables are those afected by correlations between variables; they 
became significant after adjusted multivariate analysis. The two variables in the square 
in the table fal into this category. This study result supports the rational described in 
Section 2.2.3 in Chapter I in this paper. 
 
5.2 HBM factors 
Another main objective of this paper was to organize and evaluate studies based 
on HBM. From both Studies I and I, HBM factors were shown to be potential efective 
predictors for immunizations as one preventive behavior. HBM factors that have shown 
significance in these studies and referenced studies in Japan and abroad that support the 
results of the studies in this paper are summarized in Summary Table 2. Due to 
diferent immunization characteristics investigated in the two studies, the HBM 
constructs included in the two questionnaires were diferent. This complicated 
comparing the two studies in this paper, but across diferent ages, genders and 
characteristics in the populations in Studies I and I, several common findings were 
  
154 
 
observed. The first common findings were perceived efectiveness and the belief that 
the vaccine was inefective hindering the vaccination acceptance behavior in both 
Studies I and I. The number of immunization behavior studies based on HBM is stil 
few in Japan. But these results in this paper can support many studies abroad and in 
Japan, as mentioned in the Introduction in Chapter I. Similarly, perceived severity 
backed up by the results of meta-analysis elsewhere became significant in both studies 
in this paper after univariate analysis. The lack of significance after multivariate 
analysis in both studies may have been caused by the questionnaire constructs having 
been too simple to find diferences. Further studies are necessary. The next main 
common finding was about the HBM barrier factor of fear of side efects that became 
significant after adjusted multivariate analysis in both studies. Among the maternal and 
parental studies abroad in Summary Table 2, Cheung et al. suggested that fear of side 
efects was stronger in parents with higher education (134). Related to this suggestion, 
one influenza study in the elderly population in the table of Singleton et al. reported 
that fear of side efects was a major reason for influenza vaccination rejection in a large 
scale Medicare population in the US. From these results, fear of side efects may be a 
universal cause for vaccination refusal. 
Contrary to the above common findings, diferent findings between Studies I and 
I for HBM factors were the cue to action factors. The most significant cue to action 
factor in the influenza study in the elderly population was communication from local 
government. The most predictable cue to action factor in the mumps study in the 
maternal population was a family doctor recommendation, which was folowed by 
social network factors. This may be partialy explained by the vaccination being NIP or 
not. Generaly, local governments send vaccination notifications if the vaccines are 
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included in NIP. For this reason, communication from local government became the 
most efective method for seasonal influenza vaccination acceptance among the elderly 
population. This was because the vaccination has been included in NIP for the elderly 
aged 65 years old and older. To the contrary, as already mentioned in the discussion 
section in Studies I and I, social networks beter predict parental, especialy maternal, 
choice of vaccination, and messages transmited by interpersonal networks strongly 
influence motivation to obtain vaccinations. Social networks would mainly be a benefit 
for mothers to raise vaccination acceptance for their children (62, 63, 64).  
 Diferent findings were obtained in the studies in this paper; the elderly 
significantly relied on media for vaccination information. In Study I nearly half of the 
participants relied on the media as their vaccination information source. Considering 
the above-mentioned common and diferent characteristics of HBM factors, raising 
vaccination awareness among these populations is possible. However, HBM is a 
behavioral model only at the individual level. 
 
5.3 Implication and approach proposed from the studies 
Healthy behaviors are thought to be maximized when environments and policies 
support healthful choices, and when individuals are motivated and educated to make 
those choices (Otawa Charter for Health Promotion, 1986). Glantz et al. suggest, 
“Health education includes not only instructional activities and other strategies to 
change individual health behavior but also organizational eforts, policy directives, 
economic supports, environmental activities, mass media, and community-level 
programs” (164).  Green et al. suggest health promotion as the combination of 
educational and environmental supports for actions and conditions of living conducive 
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of health (145). 
Here I discuss the implications and proposals through both Studies I and I. 
As described elsewhere, both study I and I were cross-sectional observational 
studies. In addition, participants were educated and their subjective life-standards were 
comparatively wel so that generalization to common population is unknown.  But 
through the two studies, many issues and factors afecting immunization acceptance 
have been suggested, including vaccination programs, policies, facility access, costs 
including subsidies, disbelief in vaccines, safety, vaccine scarcity, lack of information 
resources, social networks, knowledge dissemination including side efects and the 
media. 
An implication obtained from Study I; mumps vaccine has to be included in NIP 
to reduce cost barier and to feel that they were unnecessary. Also, more knowledge 
dissemination about the severity of complications when children contracted to natural 
mumps and how the vaccine could prevent them would be necessary. For mothers, 
message dissemination complied with HBM factors especialy through family doctors 
or social networks would be suficient. Also, fear of side efects and safety issues 
remains so that safety of current vaccines has to review again. 
From study I, to achieve the first objective to reduce excess mortality during 
influenza seasons, suppose adverse event incidence of current seasonal flu vaccines are 
smal, knowledge dissemination to lessen the fear of side efects and disbelief, to know 
correctly about the subsidy to lift a burden of cost. And correct information about herd 
immunity to protect vulnerable populations would be a benefit. For this population of 
the study, message dissemination based on HBM factors especialy through local 
government communications and through media would work wel. 
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However, if we remind that immunizations evolve continuously, and new vaccines 
are introduced, we always have to consider safety issues. 
Given this, personal level interventions alone wil not work wel enough to raise 
the vaccination rate. 
As described elsewhere in this paper, HBM is a model at the individual level. 
Considering the special nature of characteristics that accompany immunization and to 
address the unsolved public health goals and problems presented in this paper, a more 
multi-level approach is necessary. More concretely, a more integrated and wider range 
of approaches such as an ecological model for health promotion at intra-personal levels 
as wel as considering the natural environment, social cultural environment, 
information environment and especialy the policy environment would be appropriate. 
The ecological model was first frame-worked by Kurt et al., focusing on the 
environment outside the person, and has been further developed. Kenneth McLeroy 
and others proposed an ecological model for health promotion and defined six sources 
of influence on health behaviors: 1) intrapersonal factors, 2) social and cultural 
environment, 3) interpersonal processes and primary groups, 4) institutional factors, 5) 
community factors and 6) public policy (32). Nagata J et al. reported in their 
systematic review of seasonal influenza vaccination uptake in the elderly population 
that structural, intermediate, and healthcare-related social determinants that influenced 
on the health system, provider and individual levels (56). 
Ecological models have been widely used in many health promotions such as the 
Colorectal Cancer Control Program (CRCCP) by the Centers for Disease Control and 
Prevention (CDC) (193). To the current author’s knowledge, no established ecological 
model exists for vaccination. The author thus decided to create and propose an 
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ecological model for immunization from insights obtained through the studies in this 
dissertation. 
The six sources in immunization activities through the studies in this paper show 
as first defined source and factors found from the studies in this dissertation, 1) 
intrapersonal factors of demographics such as gender, age (Study I and I), income and 
cost (Study I); family situations such as living abroad (Study I) and living alone; 
biological factors such as cardiovascular diseases in medical histories (Study I); 
psychological factors such as fear of side efects (Study I and I), self-rated health 
(Study I), perceived severity (Study I and I), perceived vulnerability (Study I) and 
perceived eficacy (Study I and I).  Second defined source and factors found in the 
studies are; 2) social and cultural environment of the society and culture that each 
agent belong to; historical backgrounds such as immunization program development 
including withdrawal from SLV of seasonal influenza vaccine (Study I) and side 
efect incidence history such as MMR withdrawal due to high incidence of side effects 
(Study I); presumably immunization rejections and religions. The third and forth 
sources and factors obtained in the studies are; 3) interpersonal processes and primary 
groups of social support such as social networks, family, friends (Study I), counseling 
from medical professionals (Study I and I), presumably social activities and 
organizations, and exercise and healthy life style (Study I) and 4) institutional factors 
of health insurance, health care services, health care facilities for immunizations that 
can facilitate traveling to access immunization for mothers (Study I) and other 
immunization providing facilities that are open on weekends (Study I). The fifth 
sources and factors suggested from the studies are;  5) community factors of living 
places and work place environments, research implementation regarding 
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immunizations focusing on factors of non immunization (Study I and I), community 
based organizations that can support working mothers and mothers with many children 
(Study I), counseling service facilities that provide correct knowledge and information 
source (Study I and I), facility access, transportation to help mothers living in rural 
region or elderly people to vaccination facilities (Study I and I), media that can 
provide corect information (Study I), information environment (Study I and I), local 
government communication including subsidy information (Study II) and public spaces 
where information about immunizations is provided (Study I and I). And the last sixth 
sources and insights obtained from the studies are; 6) public policies of implementing 
national and local laws of immunizations such as the national immunization program 
(Study I), subsidies for immunization (Study I and I), safety review and evaluation 
(Study I and I), guideline provisions, safety database streamlining and publishing 
(Study I and I). The author aligned these resource factors and constituents in an 
ecological model in Fig. 32. 
 
5.4 Future work 
The studies in this paper demonstrate the potentiality of HBM factor analysis in 
immunization behavior for the Japanese population. As they were cross sectional studies, 
continuing same kinds of studies is necessary to further generalize the conclusions. 
 In addition, as described in the study limitations, the sample populations in both 
studies were comparatively higher educated and wel of with presumably beter social 
capital. The social capital were out of focus in the studies in this paper, but the 
problems and issues proposed in this paper such as excess mortality during influenza 
seasons due to insuficient immunization and mumps complications due to the spread 
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of the disease may be worse in populations deprived of social capital such as the 
homeless, those living alone, those with lower socioeconomic status and people living 
in temporary housing or evacuation housing due to earthquakes. Further studies 
focusing on social factors and social capital are necessary to research these 
underprivileged populations. 
Lastly, for ecological model presented in the proposal section, each constituent for 
the six sources would be necessary to evaluate and validate along with relationship of 
constituents and each sources. This process would need on site investigations and more 
studies in future. 
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Chapter V Tables and figures 
Table 
Summary Table 1  Methodology 
Comparing analytical results: Study I seasonal influenza 
vaccination study in elderly population 
 
Summary Table 2  HBM factors 
The results of analysis in the studies in this paper and referenced 
papers that support the results 
 
 
 
Figure 
Summary Figure 32 Ecology model proposal for the immunization studies in this 
paper 
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Summary Table 1 Comparing analytical results: Study II Seasonal influenza vaccination 
study in elderly population 
 
 
 
 
 
Selected variables for multivariate analysis
Candidate variables OR p value aOR p value
Age 0.53 <0.01** 0.90 0.01*
SRH 0.51 0.02*
Sports hours per a week NA 0.045*
History: cardiobascular diseases 0.57 0.08 0.26 0.016*
Flu-like symptoms within recent two years 0.54 0.002**
History: rheumatisum/gout/arthritis 5.28 0.015* 10.90 0.018*
Number of medical histories NA 0.015*
HBM factors
Perceived vulnerability to flu or cold 0.27 <0.001** 0.13 <0.001**
Perceived severity of flu 0.54 <0.01**
Perceived (non) eficacy of flu vaccine 30.04 <0.01** 35.10 <0.001**
Cue to the action
Recommendations from family doctors 0.30 0.002** 0.39 0.09
Knowing subsidy to the vaccine 0.21 <0.001** 0.21 <0.0001**
Communication from local government 0.28 0.016* 0.12 0.024*
Perceived barrier
The vaccine is expensive 1.88 0.08 7.89 0.001**
Concern over vaccine scarcity † 0.26 0.013*
Fear of harmful side efects 6.67 <0.001** 8.74 <0.001**
Being busy † NA 0.001**
WTP NA <0.001**
** denote significance of p value is less than 0.01.* denote significance of p value is less than 0.05.
†The variables were excluded from candidates variables by reasons specified in the paper.
WTP=Wiling to pay SRH=Self rated health
Univariate analysis Multivariate analysis
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Summary Table 2 HBM factors: The results of analysis in the studies in this paper and 
referenced papers that support the results 
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Summary figure 32 Ecological model of proposal for the immunization studies in this 
paper  (Author created the graph as a proposal model) 
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